TW200821372A - Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element - Google Patents

Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element Download PDF

Info

Publication number
TW200821372A
TW200821372A TW096131758A TW96131758A TW200821372A TW 200821372 A TW200821372 A TW 200821372A TW 096131758 A TW096131758 A TW 096131758A TW 96131758 A TW96131758 A TW 96131758A TW 200821372 A TW200821372 A TW 200821372A
Authority
TW
Taiwan
Prior art keywords
liquid crystal
group
crystal alignment
alignment agent
dianhydride
Prior art date
Application number
TW096131758A
Other languages
Chinese (zh)
Other versions
TWI457421B (en
Inventor
Hiroyuki Yasuda
Eiji Hayashi
Michinori Nishikawa
Original Assignee
Jsr Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jsr Corp filed Critical Jsr Corp
Publication of TW200821372A publication Critical patent/TW200821372A/en
Application granted granted Critical
Publication of TWI457421B publication Critical patent/TWI457421B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nonlinear Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Liquid Crystal (AREA)

Abstract

The present invention provides a liquid crystal alignment agent comprising an amino group substituent of 4,4'-diaminophenyl or an amino group substituent of 2,7-diaminofluorene. A liquid crystal alignment film made from the liquid crystal alignment agent has good properties of electricity and printing.

Description

200821372 九、發明說明:200821372 IX. Description of invention:

域 領 術 技 之 屬 所 明 發 rL 本發明涉及液晶配向劑、液晶配向膜和液晶顯示元 件。更具體地說,涉及能夠形成電性特性良好、且印刷性 良好的液晶配向膜的液晶配向劑,該液晶配向膜以及具有 它的液晶顯示元件。 【先前技術】 目前,作爲液晶顯示元件,已知具有所謂TN型(Twisted Nematic)液晶胞的TN型液晶顯示元件,其在設置了透明導 電膜的基板表面上形成由聚醯胺酸、聚醯亞胺等形成的液 晶配向膜,作爲液晶顯示元件用的基板,將2片該基板相 對配置,在其間隙內形成具有正介電各向異性的向列型液 晶層,構成夾層結構的晶胞,液晶分子的長軸從一片基板 向另一片基板連續地扭轉90度。並且,還開發了與TN型 液晶顯示元件相比對比度更高、其視角依賴性更小的 STN(Supei: Twisted Nematic)型液晶顯示元件和垂直配向 型液晶顯示元件。該STN型液晶顯示元件將在向列型液晶 中摻合了作爲光學活性物質的手性劑的液晶作爲液晶使 用,其利用通過使液晶分子的長軸在基板間處於連續扭轉 1 80度以上的狀態而產生的雙折射效應。相比之下,如非 專利文獻1和專利文獻1所述,提出了在ITO上形成突起 來控制液晶配向方向的被稱作爲MV A方式的垂直配向型 液晶顯示元件。MVA方式的液晶顯示元件不僅視角、對比 度等優良,而且在形成液晶配向膜的過程中還可以不進行 200821372 打磨(rubbing)處理等,因而在製程方面也是優良的。作爲 適用於TN、STN、MVA方式的液晶配向膜,需要液晶顯示 元件的殘像消除時間短等性能。另外,作爲形成該等液晶 配向膜所用的配向劑,要求在平版印刷中具有優良的印刷 性。 〔專利文獻1〕日本特開平11— 258605號公報 〔非專利文獻1〕 “液晶” V ο 1 · 3 N 〇. 2 1 1 7 ( 1 9 9 9年) 【發明內容】 本發明是鑒於上述問題而作出的,其目的是提供能夠 形成在維持電壓保持率的同時又使蓄積電荷減少的液晶配 向膜、並且具有優良的印刷性的液晶配向劑,並提供該液 晶配向膜以及採用它的液晶顯示元件。 本發明的進一步其他目的和優點可以由以下的說明看 出。 根據本發明,本發明的上述目的和優點係由一種、液晶 配向劑達成,其特徵在於含有從由下述式(A)表示@ % 和下述式(B)表示的化合物所構成群組選出的g少一種化 合物(以下,也稱爲特定化合物), /The present invention relates to a liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display element. More specifically, it relates to a liquid crystal alignment agent capable of forming a liquid crystal alignment film having good electrical characteristics and excellent printability, the liquid crystal alignment film, and a liquid crystal display element having the same. [Prior Art] At present, as a liquid crystal display element, a TN type liquid crystal display element having a so-called TN type (Twisted Nematic) liquid crystal cell is known, which is formed of polylysine, polyfluorene on the surface of a substrate provided with a transparent conductive film. A liquid crystal alignment film formed of an imine or the like is used as a substrate for a liquid crystal display element, and two substrates are arranged to face each other, and a nematic liquid crystal layer having positive dielectric anisotropy is formed in the gap to form a unit cell having a sandwich structure. The long axis of the liquid crystal molecules is continuously twisted by 90 degrees from one substrate to the other substrate. Further, STN (Supei: Twisted Nematic) type liquid crystal display elements and vertical alignment type liquid crystal display elements having higher contrast and smaller viewing angle dependence than TN type liquid crystal display elements have been developed. The STN type liquid crystal display device uses a liquid crystal in which a chiral agent as an optically active substance is blended in a nematic liquid crystal as a liquid crystal by using a long axis of liquid crystal molecules to be continuously twisted by more than 180 degrees between substrates. The birefringence effect produced by the state. In contrast, as described in Non-Patent Document 1 and Patent Document 1, a vertical alignment type liquid crystal display element called an MV A method in which protrusions are formed on ITO to control the alignment direction of liquid crystals has been proposed. The liquid crystal display element of the MVA type is excellent not only in viewing angle and contrast, but also in the process of forming a liquid crystal alignment film, and it is not necessary to perform the rubbing treatment in 200821372, and is therefore excellent in the process. As a liquid crystal alignment film suitable for the TN, STN, and MVA systems, it is required that the residual image erasing time of the liquid crystal display element is short. Further, as an alignment agent for forming the liquid crystal alignment films, it is required to have excellent printability in lithography. [Patent Document 1] Japanese Laid-Open Patent Publication No. Hei 11-258605 (Non-Patent Document 1) "Liquid Crystal" V ο 1 · 3 N 〇. 2 1 1 7 (19 9 9) [Invention] The present invention is in view of the above. The object of the present invention is to provide a liquid crystal alignment film capable of forming a liquid crystal alignment film which maintains a voltage holding ratio while reducing accumulated charges, and which has excellent printability, and provides the liquid crystal alignment film and liquid crystal using the same Display component. Still other objects and advantages of the present invention will be apparent from the following description. According to the present invention, the above objects and advantages of the present invention are achieved by a liquid crystal alignment agent characterized by containing a group consisting of a compound represented by the following formula (A): @% and the following formula (B). One less g of a compound (hereinafter, also referred to as a specific compound), /

200821372200821372

(式中,R13和Rm各自獨立地爲氫原子、院基、烷氧 基或者方香族基團’ Rl5和Rl7爲方香族基團,Ri6和Ri8 各自獨立地爲氫原子.、烷基或縮水甘油基,且X表示2價 的有機基團、-〇-或者-NH-)。 此外,本發明的液晶配向劑較佳爲還含有從由下述式 (I - 1)表示的聚醯胺酸和(I - 2)表示的聚醯亞胺所構成群 組選出的至少一種聚合物。 (1 — 1)(wherein R13 and Rm are each independently a hydrogen atom, a decyl group, an alkoxy group or a aryl group] R15 and Rl7 are a scented group, and Ri6 and Ri8 are each independently a hydrogen atom. Or a glycidyl group, and X represents a divalent organic group, -〇- or -NH-). Further, the liquid crystal alignment agent of the present invention preferably further contains at least one polymerization selected from the group consisting of polylysine represented by the following formula (I-1) and polyimine represented by (I-2). Things. (1 - 1)

HOOC、 /COOH HNOC CONH—Q1 (式中,P1爲4價的有機基團,且Q1爲2價的有機基 團), 200821372 ο οHOOC, /COOH HNOC CONH-Q1 (wherein P1 is a tetravalent organic group, and Q1 is a divalent organic group), 200821372 ο ο

(式中,Ρ2爲4價的有機基團,且Q2爲2價的有機基 團)。 根據本發明之液晶配向劑,可以提供能夠形成在維持 電壓保持率的同時又使蓄積電荷減少的液晶配向膜,並且 具有優良的印刷性的液晶配向劑、其液晶配向膜以及具有 它的液晶顯示元件。 【實施方式】 以下,對本發明進行更詳細的說明。 本發明的液晶配向劑通過使特定化合物和較佳爲進一 步由聚醯胺酸和聚醯亞胺所選出的至少一種聚合物(以 下,也稱爲特定聚合物)溶解於有機溶劑中而構成。 [特定化合物1] 將式(Α)表示的化合物稱作爲特定化合物1。 在式(Α)中,R8各自獨立地爲氫原子、烷基、烷氧 基或芳香族基團。作爲烷基和烷氧基,具體而言較佳爲碳 數爲1〜6的烷基、碳數爲1〜6的烷氧基。作爲烷基和烷 執基中的院基’可以舉例如甲基、乙基、正丙基、異丙基、 正丁基、2 -甲基-丙基、3 -甲基-丙基、正戊基、正己基。另 外,作爲Ri〜R8的芳香族基團,可以舉出苯基。R9、R10 200821372 爲芳香族基團,具體地可以舉出苯基、萘基。R1G、R12各 自獨立地爲氫原子、烷基或縮水甘油基’作爲烷基,可以 舉出甲基、乙基、丙基、丁基。 式(A)中,較佳爲R2、R4、R5和R7爲氨,Ri、R3、R6 和R8各自獨立地爲氫、甲基或乙基,R9、Rm均爲苯基, R 1 0、R 1 2爲縮水甘油基。 作爲特定化合物1的具體化合物,可以舉出以下的化(wherein Ρ2 is a tetravalent organic group, and Q2 is a divalent organic group). According to the liquid crystal alignment agent of the present invention, it is possible to provide a liquid crystal alignment film capable of forming a liquid crystal alignment film while maintaining a voltage holding ratio while reducing accumulated charge, and having excellent printability, a liquid crystal alignment film thereof, and a liquid crystal display having the same element. [Embodiment] Hereinafter, the present invention will be described in more detail. The liquid crystal alignment agent of the present invention is constituted by dissolving a specific compound and at least one polymer (hereinafter, also referred to as a specific polymer) selected from polyphthalic acid and polyimine in an organic solvent. [Specific Compound 1] A compound represented by the formula (Α) is referred to as a specific compound 1. In the formula (Α), R8 is each independently a hydrogen atom, an alkyl group, an alkoxy group or an aromatic group. Specific examples of the alkyl group and the alkoxy group are an alkyl group having 1 to 6 carbon atoms and an alkoxy group having 1 to 6 carbon atoms. Examples of the alkyl group in the alkyl group and the alkyl group include methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, 2-methyl-propyl group, 3-methyl-propyl group, and a positive group. Amyl, n-hexyl. Further, examples of the aromatic group of Ri to R8 include a phenyl group. R9 and R10 200821372 are aromatic groups, and specific examples thereof include a phenyl group and a naphthyl group. R1G and R12 each independently represent a hydrogen atom, an alkyl group or a glycidyl group. The alkyl group may, for example, be a methyl group, an ethyl group, a propyl group or a butyl group. In the formula (A), preferably R2, R4, R5 and R7 are ammonia, and Ri, R3, R6 and R8 are each independently hydrogen, methyl or ethyl, R9 and Rm are each a phenyl group, R 1 0, R 1 2 is a glycidyl group. Specific examples of the specific compound 1 include the following

另外’在上述化合物中,Me爲甲基,Et表示乙基。 [特定化合物2] 將式(B)表示的化合物稱作爲特定化合物2。 在式(B)中,Rls、r14各自獨立地爲氫原子、烷基、烷 氧基或芳香族基團。作爲烷基和烷氧基,具體而言較佳爲 碳數爲1〜6的烷基、碳數爲丨〜6的烷氧基。作爲烷基和 200821372 烷氧基中的烷基,可以舉例如甲基、乙基、正丙基、異丙 基、正丁基、2-甲基·丙基、3·甲基-丙基、正戊基、正己基。 另外,作爲R13、R14的芳香族基團,可以舉出苯基。R15、 R17爲芳香族基團,具體地可以舉出苯基、萘基。r16、r18 各自獨立地爲氫原子、烷基或縮水甘油基,作爲烷基,可 以舉出甲基、乙基、丙基、丁基。 X爲2價的有機基團、-〇-或-NH-。作爲較佳的2價有 機基團,可以舉例如-CH2-或者-CH2CH2·。 式(B)中,較佳爲r13、r14爲氫,r15、r17均爲苯基, Rl6、Ri8 爲縮水甘油基,X 爲-NH-、-CH2-或者-CH2CH2-。 作爲特定化合物2的具體化合物,可以舉出以下的化 合物。Further, in the above compounds, Me is a methyl group and Et represents an ethyl group. [Specific Compound 2] The compound represented by the formula (B) is referred to as the specific compound 2. In the formula (B), Rls and r14 are each independently a hydrogen atom, an alkyl group, an alkoxy group or an aromatic group. Specific examples of the alkyl group and the alkoxy group are preferably an alkyl group having 1 to 6 carbon atoms and an alkoxy group having a carbon number of 丨6. Examples of the alkyl group in the alkyl group and the 200821372 alkoxy group include a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a n-butyl group, a 2-methyl-propyl group, and a 3-methyl-propyl group. N-pentyl, n-hexyl. Further, examples of the aromatic group of R13 and R14 include a phenyl group. R15 and R17 are an aromatic group, and specific examples thereof include a phenyl group and a naphthyl group. R16 and r18 each independently represent a hydrogen atom, an alkyl group or a glycidyl group, and examples of the alkyl group include a methyl group, an ethyl group, a propyl group and a butyl group. X is a divalent organic group, -〇- or -NH-. As a preferable divalent organic group, for example, -CH2- or -CH2CH2. In the formula (B), it is preferred that r13 and r14 are hydrogen, r15 and r17 are all phenyl groups, Rl6 and Ri8 are glycidyl groups, and X is -NH-, -CH2- or -CH2CH2-. Specific compounds of the specific compound 2 include the following compounds.

[聚醯胺酸] <四羧酸二酸酐> 作爲上述聚醯胺酸合成中所用的四竣酸二酸酐,可以 -10- 200821372 使用脂環式四羧酸二酸酐、脂肪族四羧酸二酸酐或者芳香 族四羧酸二酸酐。其中較佳爲脂環式四羧酸二酸酐。作爲 脂環式四羧酸二酸酐的具體例子,例如,可以舉出1,2,3,4-環丁烷四羧酸二酸酐、1,2-二甲基-1,2,3,4-環丁烷四羧酸二 酸酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酸酐、1,3-二氯 -1,2,3,4-環丁烷四羧酸二酸酐、1,2,3,4-四甲基-1,2,3,4-環 丁烷四羧酸二酸酐、1,2,3,4-環戊烷四羧酸二酸酐、1,2,4,5-環己烷四羧酸二酸酐、3,3’,4,4’-二環己基四羧酸二酸酐、 順式_3,7_二丁基環辛-1,5-二烯-1,2,5,6-四羧酸二酸酐、 2,3,5-三羧基環戊基醋酸二酸酐、3,5,6-三羧基-2-羧基降冰 片烷-2: 3,5: 6-二酸酐、2,3,4,5-四氫呋喃四羧酸二酸酐、 l,3,3a,4,5,9b-六氫-5-(四氫-2,5-二氧代-3-呋喃基)-萘 [l,2-c]-呋喃-1,3-二酮、l,3,3a,4,5,9b-六氫-5-甲基·5-(四氫 -2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、 1,3,3&,4,5,91>-六氫-5-乙基-5-(四氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、l,3,3a,4,5,9b-六氫-7-甲基- 5-(四 氫-2,5 -二氧代-3 -呋喃基)-萘[l,2-c] -呋喃-1,3 -二酮、 1,3,3&,4,5,91)_六氫-7-乙基-5-(四氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、1,3,3&,4,5,91>-六氫-8-甲基-5-(四 氫-2,5-二氧代-3-呋喃基)-萘[1,2-〇]-呋喃-1,3-二酮、 1,3,3&,4,5,913_六氫_8-乙基-5-(四氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、1,3,3&,4,5,91^-六氫-5,8-二甲基 -5-(四氫-2,5-二氧代-3-呋喃基萘[l,2-c]-呋喃-1,3-二 \ 酮、5-(2,5-二氧代四氫呋喃亞甲基)-3-甲基-3-環己烯-1,2- 200821372 二羧酸二酸酐、雙環[2.2.2]-辛-7-烯-2,3,5,6-四羧酸二酸 酐、3-氧雜雙環[3·2·1]辛烷-2,4-二酮-6_螺-3’-(四氫肤喃 -2’,5’-二酮)、5-(2,5-二氧代四氫-3-呋喃基)-3-甲基-3-環己 烯-1,2-二羧酸酸酐、3,5,6-三羧基-2-羧基降冰片烷-2: 3,5 : 6-二酸酐、4,9-二氧雜三環[5.3.1.02,6]十一烷-3,5,8,10-四 酮、下述式(I)和(Π)表示的化合物,[Polyuric acid] <tetracarboxylic dianhydride> As the tetracarboxylic acid dianhydride used in the synthesis of the above polylysine, alicyclic tetracarboxylic dianhydride or aliphatic tetracarboxylic acid can be used as -10-200821372 Acid dianhydride or aromatic tetracarboxylic acid dianhydride. Among them, an alicyclic tetracarboxylic acid dianhydride is preferred. Specific examples of the alicyclic tetracarboxylic acid dianhydride include 1,2,3,4-cyclobutanetetracarboxylic acid dianhydride and 1,2-dimethyl-1,2,3,4. - cyclobutane tetracarboxylic acid dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutane tetracarboxylic acid dianhydride, 1,3-dichloro-1,2,3,4- Cyclobutane tetracarboxylic acid dianhydride, 1,2,3,4-tetramethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,2,3,4-cyclopentane IV Carboxylic acid dianhydride, 1,2,4,5-cyclohexanetetracarboxylic acid dianhydride, 3,3',4,4'-dicyclohexyltetracarboxylic dianhydride, cis_3,7-dibutyl Cyclooctane-1,5-diene-1,2,5,6-tetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 3,5,6-tricarboxy-2 -carboxynorbornane-2: 3,5:6-dianhydride, 2,3,4,5-tetrahydrofuran tetracarboxylic acid dianhydride, 1,3,3a,4,5,9b-hexahydro-5-( Tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro- 5-methyl·5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]-furan-1,3-dione, 1,3,3&4,5,91>-hexahydro-5-ethyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]- Furan-1,3-diketone, 1,3,3a,4,5,9b-hexahydro-7-methyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]-furan-1,3-dione, 1,3,3&,4,5,91)_hexahydro-7-ethyl-5-(tetrahydro-2,5-di Oxo-3-furanyl)-naphthalene [l,2-c]-furan-1,3-dione, 1,3,3&,4,5,91>-hexahydro-8-methyl-5 -(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene[1,2-indolyl]-furan-1,3-dione, 1,3,3&,4,5,913_hexahydrogen _8-ethyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c]-furan-1,3-dione, 1,3,3& ,4,5,91^-hexahydro-5,8-dimethyl-5-(tetrahydro-2,5-dioxo-3-furanylnaphthalene [l,2-c]-furan-1, 3-di-ketone, 5-(2,5-dioxotetrahydrofuranmethylene)-3-methyl-3-cyclohexene-1,2- 200821372 dicarboxylic acid dianhydride, bicyclo [2.2.2] -oct-7-ene-2,3,5,6-tetracarboxylic dianhydride, 3-oxabicyclo[3·2·1]octane-2,4-dione-6-spiro-3'- (tetrahydrofuran-2',5'-dione), 5-(2,5-dioxotetrahydro-3-furanyl)-3-methyl-3-cyclohexene-1,2- Dicarboxylic acid anhydride, 3,5,6-tricarboxy-2-carboxynorbornane-2: 3,5:6-dianhydride, 4,9-dioxo a heterotricyclo[5.3.1.02,6]undecane-3,5,8,10-tetraone, a compound represented by the following formula (I) and (Π),

(式中,R1和R3表示具有芳香環的2價有機基團,R2 和R4表示氫原子或者烷基,多個存在的R2和1^4各自可以 相同,也可以不同)。 另外,還可以舉出丁烷四羧酸二酸酐等脂肪族四羧酸 二酸酐;均苯四酸二酸酐、3,3’,4,4’-二苯酮四羧酸二酸酐、 3,3’,4,45-二苯基颯四羧酸二酸酐、1,4,5,8-萘四羧酸二酸 酐、2,3,6,7-萘四羧酸二酸酐、3,3’,4,4’-二苯基醚四羧酸二 酸酐、.3,3’,4,45-二甲基二苯基矽烷四羧酸二酸酐、 3,3’,4,4’-四苯基矽烷四羧酸二酸酐、1,2,3,4-呋喃四羧酸二 200821372 酸酐、4,4’-二(3,4-二羧基苯氧基)二苯基硫醚二酸酐、4,4’-二(3,4-二羧基苯氧基)二苯基颯二酸酐、4,4’-二(3,4-二羧 基苯氧基)二苯基丙烷二酸酐、3,3’,4,4’-全氟異亞丙基二苯 二甲酸二酸酐、2,2’,3,3’-聯苯四羧酸二酸酐、3,3’,4,4’-聯 苯四羧酸二酸酐、二(苯二甲酸)苯膦氧化物二酸酐、對-伸 苯基-二(三苯基苯二甲酸)二酸酐、間-亞苯基-二(三苯基苯 二甲酸)二酸酐、二(三苯基苯二甲酸)-4,4’-二苯醚二酸酐、 二(三苯基苯二甲酸)-4,4’-二苯基甲烷二酸酐、乙二醇-二 ® (脫水偏苯三酸酯)、丙二醇-二(脫水偏苯三酸酯)、1,4·丁二 醇-二(脫水偏苯三酸酯)、〗,6-己二醇-二(脫水偏苯三酸 酯)、1,8-辛二醇-二(脫水偏苯三酸酯)、2,2-二(4·羥苯基.) 丙烷-二(脫水偏苯三酸酯)、下述式(1)〜(4)表示的化合物 等芳香族四羧酸二酸酐。它們可以1種單獨或2種以上組 合使用。(wherein R1 and R3 represent a divalent organic group having an aromatic ring, R2 and R4 represent a hydrogen atom or an alkyl group, and a plurality of R2 and 1^4 present may be the same or different). Further, an aliphatic tetracarboxylic acid dianhydride such as butane tetracarboxylic acid dianhydride; pyromellitic dianhydride; 3,3',4,4'-benzophenonetetracarboxylic dianhydride; 3',4,45-diphenylstilbene tetracarboxylic acid dianhydride, 1,4,5,8-naphthalenetetracarboxylic acid dianhydride, 2,3,6,7-naphthalenetetracarboxylic acid dianhydride, 3,3 ',4,4'-diphenyl ether tetracarboxylic acid dianhydride, .3,3',4,45-dimethyldiphenylnonane tetracarboxylic acid dianhydride, 3,3',4,4'- Tetraphenylnonane tetracarboxylic acid dianhydride, 1,2,3,4-furan tetracarboxylic acid II 200821372 anhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenyl sulfide dianhydride 4,4'-bis(3,4-dicarboxyphenoxy)diphenylsebacic dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenylpropane dianhydride, 3 , 3',4,4'-perfluoroisopropylidene di phthalic anhydride, 2,2',3,3'-biphenyltetracarboxylic dianhydride, 3,3',4,4'- Biphenyltetracarboxylic acid dianhydride, di(phthalic acid) phenylphosphine oxide dianhydride, p-phenylene-bis(triphenylphthalic acid) dianhydride, m-phenylene-bis(triphenyl) Phthalic acid) dianhydride, di(triphenylene) Phthalic acid)-4,4'-diphenyl ether dianhydride, bis(triphenylphthalic acid)-4,4'-diphenylmethane dianhydride, ethylene glycol-di® (dehydrated trimellitic acid) Ester), propylene glycol-di (dehydrated trimellitate), 1,4-butanediol-di(anhydrotrimellitic acid ester), 〗 〖, 6-hexanediol-di(dehydrated trimellitic acid ester) 1,8-octanediol-di(anhydrotrimellitic acid ester), 2,2-bis(4-hydroxyphenyl.)propane-di(anhydrotrimellitic acid ester), the following formula (1) An aromatic tetracarboxylic acid dianhydride such as a compound represented by (4). They may be used alone or in combination of two or more.

-13- 200821372-13- 200821372

οο

οο

^CH3 \ CH3 (2)^CH3 \ CH3 (2)

?Η3Η3

/CH3 ^CH3 (3)/CH3 ^CH3 (3)

上述四狻酸二酸酐中,從能夠使其表現良好的液晶配 向性的角度出發,較佳爲1,2,3,4-環丁烷四羧酸二酸酐、 1,3-二甲基-1,2,3,4-環丁烷四羧酸二酸酐、1,2,3,4-四甲基 -14- 200821372 -1,2,3,4-環丁烷四羧酸二酸酐、1,2,3,4-環戊烷四竣酸二酸 酐、2,3,5-三羧基環戊基醋酸二酸酐、5-(2,5-二氧代四氨咲 喃亞甲基)-3-甲基-3-環己烯-1,2-二羧酸二酸酐、順式_3 7_ 二丁基環辛-1,5-二烯-1,2,5,6-四羧酸二酸酐、3,5,6-三竣基 -2-羧基降冰片烷·2 : 3,5 : 6-二酸酐、l,3,3a,455,9b_A 氨 -5-(四氫-2,5-二氧代-3-呋喃基)-萘[l,2-c]-呋喃-u-二 酮、1,3,3&,4,5,91>-六氫-8-甲基-5-(四氫-2,5-二氧代_3-咲喃 基)-萘[1,2·χ]_ 呋喃-1,3-二酮、1,3,33,4,5,91^六氫-5,8-二甲 基-5-(四氫-2,5-二氧代-3-呋喃基)-萘[1,2-〇]-呋喃_1,3-二 酮、雙環[2.2.2]-辛-7-烯-2,3,5,6-四羧酸二酸酐、3_氧雜雙 環[3·2·1]辛烷-2,4-二酮-6-螺·3,_(四氫呋喃-2,,5,_二酮)、 5_(2,5-二氧代四氫-3-呋喃基)-3-甲基-3-環己烯-丨,2-二羧 酸酸酐、3,5,6-三羧基-2-羧基降冰片烷-2 : 3,5 : 6-二酸酐、 4,9_二氧雜三環[5.3.1.02,6]十一烷-3,5,8,10-四酮、上述式 (1)表示的化合物中的下述式(5)〜(7)表示的化合物等脂環 式四羧酸二酸酐以及上述式(II)表示的化合物中的下述式 (8)表示的化合物等脂環式四羧酸二酸酐,作爲特佳者,可 以舉出1,2,3,4·環丁烷四羧酸二酸酐、1,3-二甲基·1,2,3,4-環丁烷四羧酸二酸酐、2,3,5 -三羧基環戊基醋酸二酸酐、 六氫-5-(四氫-2,5-二氧代-3-呋喃基)-萘 Π,2-c]-呋喃-13-二酮、順式-3,7-二丁基環辛-1,5-二烯 •1,2,5,6-四羧酸二酸酐、3,5,.6-三羰基-2-羧基降冰片烷-2 : 3,5: 6-二酸酐、1,3,3&,4,5,91^六氫-8-甲基-5-(四氫-2,5-二 氧代-3-呋喃基)-萘[l,2-c]-呋喃-1,3-二酮、3-氧雜雙環 200821372 ,,5,-二酮)、 L 烯-1,2-二羧 ;:6 -二酸酐、 3酮、和下述 [3.2.1]辛烷-2,4-二酮-6-螺-3’-(四氫呋喃-2 5-(2,5-二氧代四氫-3-呋喃基)-3 -甲基-3_環[ 酸酸酐、3,5,6-三羧基-2-羧基降冰片烷_2 : 3,: 4,9-二氧雜三環[5.3.1.02,6]十一烷-3,5,8,10-1; 式(5)表示的化合物。Among the above tetradecanoic acid dianhydrides, 1,2,3,4-cyclobutanetetracarboxylic dianhydride and 1,3-dimethyl- are preferable from the viewpoint of being able to exhibit good liquid crystal alignment properties. 1,2,3,4-cyclobutanetetracarboxylic acid dianhydride, 1,2,3,4-tetramethyl-14-200821372-1,2,3,4-cyclobutanetetracarboxylic acid dianhydride, 1,2,3,4-cyclopentane tetraphthalic acid dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 5-(2,5-dioxotetraammonium methylene) 3-methyl-3-cyclohexene-1,2-dicarboxylic acid dianhydride, cis_3 7-dibutylcyclooctane-1,5-diene-1,2,5,6-tetracarboxylic acid Acid dianhydride, 3,5,6-trimethyl-2-carboxynorbornane·2: 3,5:6-dianhydride, 1,3,3a,455,9b_A ammonia-5-(tetrahydro-2 ,5-dioxo-3-furanyl)-naphthalene [l,2-c]-furan-u-dione, 1,3,3&,4,5,91>-hexahydro-8-methyl -5-(tetrahydro-2,5-dioxo-3-pyranyl)-naphthalene [1,2·χ]_furan-1,3-dione, 1,3,33,4,5, 91^Hexahydro-5,8-dimethyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene[1,2-indolyl]-furan-1,3-dione Bicyclo[2.2.2]-oct-7-ene-2,3,5,6-tetracarboxylic dianhydride, 3_oxabicyclo[3·2·1]octane -2,4-dione-6-spiro-3,_(tetrahydrofuran-2,5,-dione), 5-(2,5-dioxotetrahydro-3-furanyl)-3-methyl -3-cyclohexene-indole, 2-dicarboxylic acid anhydride, 3,5,6-tricarboxy-2-carboxynorbornane-2: 3,5:6-dianhydride, 4,9-dioxa a tricyclic [5.3.1.02,6]undecane-3,5,8,10-tetraketone, a compound represented by the following formula (5) to (7) in the compound represented by the above formula (1); An alicyclic tetracarboxylic dianhydride such as a compound represented by the following formula (8) in the compound represented by the above formula (II), and the like, and 1, 2, 3, 4. Cyclobutane tetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride , hexahydro-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthoquinone, 2-c]-furan-13-dione, cis-3,7-dibutyl ring Oct-1,5-diene•1,2,5,6-tetracarboxylic dianhydride, 3,5,.6-tricarbonyl-2-carboxynorbornane-2 : 3,5: 6-dianhydride 1,3,3&,4,5,91^hexahydro-8-methyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphthalene [l,2-c] -furan-1,3-diketone, 3-oxa Ring 200821372,,5,-dione), L-ene-1,2-dicarboxyl;:6-dianhydride, 3-ketone, and the following [3.2.1]octane-2,4-dione-6- Spiro-3'-(tetrahydrofuran-2 5-(2,5-dioxotetrahydro-3-furanyl)-3-methyl-3_cyclo[acid anhydride, 3,5,6-tricarboxy-2 -carboxynorbornane_2 : 3,: 4,9-dioxatricyclo[5.3.1.02,6]undecane-3,5,8,10-1; a compound represented by the formula (5).

作爲脂環式四羧酸二酸酐以外的其他四 較佳的四羧酸二酸酐,可以舉例如丁烷四羧 苯四酸二酸酐、3,3’,4,4’-二苯酮四羧酸二酸 二苯基楓四羧酸二酸酐、2,2’,3,3’-聯苯四 1,4,5,8-萘四羧酸二酸酐等。 羧酸二酸酐中 酸二酸酐、均 酐、3,3,,4,4,-竣酸二酸酐、 -16- 200821372 這些四竣酸二酸If中,較佳爲脂環式四竣酸二酸酐相 對於全部四羧酸二酸酐爲5 0莫耳%以上。 <二胺> 作爲聚醯胺酸合成中所用的二胺,例如,可以舉出對_ 苯二胺、間-苯二胺、4,4、二胺基二苯基甲烷、4,4、二胺基 二苯基乙烷、4,4’-二胺基二苯基硫醚、4,4,-二胺基二苯基 碾、2,2’· 一甲基-4,4’-二胺基聯苯、3,3,·二甲基_4,4,-二胺 基聯苯、4,4’-二胺基苯甲醯苯胺、4,4,-二胺基二苯醚、 二胺基萘、2,2’-二三氟甲基_4,4,_二胺基聯苯、3,3,_二三 氟甲基-4,4’-一胺基聯苯、5·胺基胺基苯基)-i,3,3-三甲基茚滿、6-胺基-1-(45_胺基苯基)-l,3,3-三甲基茚滿、 3,4’·二胺基二苯基醚、3,3’-二胺基二苯酮、3,4,·二胺基二 苯酮、4,4’-二胺基二苯酮、2,2-二[4-(4-胺基苯氧基)苯基] 丙烷、2,2-二[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2-二(4-胺基苯基)六氟丙烷、2,2 -二[4-(4 -胺基苯氧基)苯基]楓、1,4-一 (4_胺基苯氧基)苯、1,3-二(4-胺基苯氧基)苯、ι,3-二(3 _ 胺基苯氧基)苯、9,9-二(4-胺基苯基)-10 -氫蒽、2,7-二胺基 芴、9,9-二甲基-2,7-二胺基芴、9,9-二(4·胺基苯基)芴、4,4,-伸甲基-二(2·氯苯胺)、2,2,,5,5’-四氯-4,4、二胺基聯苯、 2,2’-二氯-4,4’-二胺基-5,5,-二甲氧基聯苯、3,3,-二甲氧基 _4,4’_二胺基聯苯、1,4,4’-(對-伸苯基異亞丙基)二苯胺、 4,4’-(間-伸苯基異亞丙基)二苯胺、2,2,-二[4-(4-胺基-2-三 氟甲基苯氧基)苯基]六氟丙烷、4,4’-二胺基- 2,2,-二(三氟 甲基)聯苯、4,4’·二[(4-胺基-2-三氟甲基)苯氧基]-八氟聯苯 200821372 等芳香族二胺; 1,1-間苯二甲胺、1,3-丙二胺、丁二胺、戊二胺、己二' 胺、庚二胺、辛二胺、壬二胺、4,4-二胺基庚二胺、1,4-二胺基環己烷、異佛爾酮二胺、四氫二環戊二烯二胺、六 氫-4,7-甲撐茚二伸甲基二胺、三環[6·2 ·1.02’7]-十一碳烯二 甲基二胺、4,4’-伸甲基二(環己胺)等脂肪族和脂環式二胺; 2,3·二胺基吡啶、2,6-二胺基吡啶、3,4-二胺基吡啶、 2,4 ·二胺基嘧啶、5,6 -二胺基-2 5 3 -二氰基吡曝、5,6 -二胺基 -2,4-二羥基嘧啶、2,4-二胺基-6-二甲胺基-1,3,5-三嗪、1,4-二(3-胺基丙基)呱嗪、2,4-二胺基-6-異丙氧基-1,3,5-三嗪、 2,4-二胺基-6-甲氧基-1,3,5-三嗪、2,4-二胺基-6-苯基 -1,3,5-三嗪、2,4-二胺基-6-甲基-s·三嗪、2,4-二胺基-1,3,5-三嗪、4,6-二胺基-2-乙烯基-s-三嗪、2,4-二胺基-5-苯基噻 唑、2,6-二胺基嘌呤、5,6-二胺基-1,3-二甲基尿嘧啶、3,5-二胺基-1,2,4·三唑、6,9-二胺基-2-乙氧基吖啶乳酸酯、3,8-二胺基-6-苯基菲啶、1,4-二胺基呱嗪、3,6-二胺基吖啶、 二(4-胺基苯基)苯基胺、3,6-二胺基咔唑、Ν-甲基-3,6-二胺 基咔唑、Ν -乙基-3,6 -二胺基咔唑、Ν -苯基-3,6 -二胺基咔唑 等之分子內具有2個1級胺基以及該1級胺基以外的氮原 子的二胺;下述式(V)表示的二胺基有機矽氧烷等。這些二 胺可以單獨或者2種以上組合使用。As the other four preferred tetracarboxylic dianhydrides other than the alicyclic tetracarboxylic dianhydride, for example, butane tetracarboxylic pyrogate dianhydride and 3,3',4,4'-benzophenone tetracarboxylate are mentioned. Diphenyl maple tetracarboxylic acid dianhydride, 2,2',3,3'-biphenyltetra-1,4,5,8-naphthalenetetracarboxylic acid dianhydride, and the like. In the carboxylic acid dianhydride, the acid dianhydride, the retic anhydride, the 3,3,4,4,-decanoic acid dianhydride, -16-200821372, among these tetradecanoic acid diacids, the alicyclic tetradecanoic acid II is preferred. The acid anhydride is 50 mol% or more based on the entire tetracarboxylic acid dianhydride. <Diamine> Examples of the diamine used in the synthesis of polylysine include p-phenylenediamine, m-phenylenediamine, 4,4, diaminodiphenylmethane, and 4,4. , diaminodiphenylethane, 4,4'-diaminodiphenyl sulfide, 4,4,-diaminodiphenyl milling, 2,2'·monomethyl-4,4' -diaminobiphenyl, 3,3,-dimethyl-4,4,-diaminobiphenyl, 4,4'-diaminobenzimidamide, 4,4,-diaminodiphenyl Ether, diaminonaphthalene, 2,2'-ditrifluoromethyl_4,4,-diaminobiphenyl, 3,3,-ditrifluoromethyl-4,4'-monoaminobiphenyl ,5.Aminoaminophenyl)-i,3,3-trimethylindan, 6-amino-1-(45-aminophenyl)-l,3,3-trimethylindan , 3,4'-diaminodiphenyl ether, 3,3'-diaminobenzophenone, 3,4,diaminobenzophenone, 4,4'-diaminobenzophenone, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 2,2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2- Bis(4-aminophenyl)hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)phenyl]leaf, 1,4-mono(4-aminophenoxy)benzene 1,3-bis(4-aminophenoxy) , ι,3-di(3 _aminophenoxy)benzene, 9,9-bis(4-aminophenyl)-10-hydroquinone, 2,7-diaminopurine, 9,9-di Methyl-2,7-diaminopurine, 9,9-bis(4.aminophenyl)anthracene, 4,4,-methyl-bis(2·chloroaniline), 2,2,,5 , 5'-tetrachloro-4,4,diaminobiphenyl, 2,2'-dichloro-4,4'-diamino-5,5,-dimethoxybiphenyl, 3,3, -dimethoxy_4,4'-diaminobiphenyl, 1,4,4'-(p-phenylene isopropylidene)diphenylamine, 4,4'-(meta-phenylene) Propylene)diphenylamine, 2,2,-bis[4-(4-amino-2-trifluoromethylphenoxy)phenyl]hexafluoropropane, 4,4'-diamino-2, An aromatic diamine such as 2,-bis(trifluoromethyl)biphenyl, 4,4'-bis[(4-amino-2-trifluoromethyl)phenoxy]-octafluorobiphenyl 200821372; , 1-m-xylylenediamine, 1,3-propanediamine, butanediamine, pentamethylenediamine, hexamethylenediamine, heptanediamine, octanediamine, decanediamine, 4,4-diaminoglycol Diamine, 1,4-diaminocyclohexane, isophoronediamine, tetrahydrodicyclopentadienyldiamine, hexahydro-4,7-methylene quinone dimethylenediamine, tricyclic [6·2 ·1.02'7]-undecene Aliphatic and alicyclic diamines such as diamine, 4,4'-methylbis(cyclohexylamine); 2,3·diaminopyridine, 2,6-diaminopyridine, 3,4- Diaminopyridine, 2,4 · diaminopyrimidine, 5,6-diamino-2 5 3 -dicyanopyridine, 5,6-diamino-2,4-dihydroxypyrimidine, 2, 4-diamino-6-dimethylamino-1,3,5-triazine, 1,4-bis(3-aminopropyl)pyridazine, 2,4-diamino-6-isopropyl Oxy-1,3,5-triazine, 2,4-diamino-6-methoxy-1,3,5-triazine, 2,4-diamino-6-phenyl-1, 3,5-triazine, 2,4-diamino-6-methyl-s-triazine, 2,4-diamino-1,3,5-triazine, 4,6-diamino- 2-vinyl-s-triazine, 2,4-diamino-5-phenylthiazole, 2,6-diaminopurine, 5,6-diamino-1,3-dimethyluracil , 3,5-diamino-1,2,4.triazole, 6,9-diamino-2-ethoxyacridine lactate, 3,8-diamino-6-phenylphenanthrene Pyridine, 1,4-diaminopyridazine, 3,6-diaminoacridine, bis(4-aminophenyl)phenylamine, 3,6-diaminocarbazole, oxime-methyl- Molecules such as 3,6-diaminocarbazole, oxime-ethyl-3,6-diaminocarbazole, oxime-phenyl-3,6-diaminocarbazole 1 having two stages and the amine nitrogen atom of the stage 1 group other than a diamine; siloxane diamine and the like silicones represented by the following formula (V). These diamines may be used alone or in combination of two or more.

(V) 200821372 (式中,R5表示碳數爲1〜12的烴基,多個存在的R5 各自可以相同也可以不同,P爲1〜3的整數,9爲}〜2〇 的整數)。 , 其中,較佳爲對-苯二胺、4,4’-二胺基二苯甲烷、4,4,_ 二胺基二苯硫醚、2,2’-二甲基·4,4’_二胺基聯苯、U —二胺 基萘、2,2’-二三氟甲基-4,4’-二胺基聯苯、257 -二胺基芴、 9,9-二甲基-2,7-二胺基芴、4,4’-二胺基二苯醚、2,八二 [4-(4-胺基苯氧基)苯基]丙烷、9,9-二(4-胺基苯基)芴、2,2-® 二[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2-二(4-胺基苯基) 六氟丙烷、4,4’-(對-伸苯基二異亞丙基)二苯胺、4,4,-(間· 伸苯基二異亞丙基)二苯胺、1,4-環己烷二胺、4,4,-伸甲基 二(環己胺)、1,4-二(4-胺基苯氧基)苯、4,4’-二(4-胺基苯氧 基)聯苯、2,6-二胺基吡啶、3,4-二胺基吡啶、2,4-二胺基嚼 啶、3,6-二胺基吖啶、3,6·二胺基咔唑、Ν-甲基_3,6-二胺基 咔唑、Ν -乙基-3,6 -二胺基咔唑、Ν -苯基-3,6 -二胺基咔唑等。 • 在使本發明液晶配向劑具有預傾角表現性能時,較佳 爲上述式(I 一 1)、(Ι— 2)中的Qi、Q2的一部分或全部爲下 述式(Q— 1)和下述式(Q — 2)袠示的至少一種基團。即,採 用具有下述式(Q — 1)或下述式(q — 2)表示的基團的二胺 (以下也稱爲‘‘特定二胺”)。它們可以丨種單獨或2種以 上組合使用。(V) 200821372 (wherein R5 represents a hydrocarbon group having 1 to 12 carbon atoms, and a plurality of R5 groups may be the same or different, P is an integer of 1 to 3, and 9 is an integer of 〜2 )). Among them, p-phenylenediamine, 4,4'-diaminodiphenylmethane, 4,4,-diaminodiphenyl sulfide, 2,2'-dimethyl-4,4' are preferred. _Diaminobiphenyl, U-diaminonaphthalene, 2,2'-ditrifluoromethyl-4,4'-diaminobiphenyl, 257-diamino hydrazine, 9,9-dimethyl -2,7-diaminopurine, 4,4'-diaminodiphenyl ether, 2, octa[4-(4-aminophenoxy)phenyl]propane, 9,9-di (4 -aminophenyl)anthracene, 2,2-® bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 4,4'-(p-phenylphenyldiisopropylidene)diphenylamine, 4,4,-(m-phenylene diisopropylidene)diphenylamine, 1,4-cyclohexanediamine, 4,4,-Extension methyl bis(cyclohexylamine), 1,4-bis(4-aminophenoxy)benzene, 4,4'-bis(4-aminophenoxy)biphenyl, 2 ,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopickylate, 3,6-diaminoacridine, 3,6-diaminocarbazole, guanidine-A Alkyl-3,6-diaminocarbazole, oxime-ethyl-3,6-diaminocarbazole, fluorenyl-phenyl-3,6-diaminocarbazole, and the like. • When the liquid crystal alignment agent of the present invention has a pretilt performance performance, it is preferred that some or all of Qi and Q2 in the above formulas (I-1) and (Ι-2) are represented by the following formula (Q-1) and At least one group represented by the following formula (Q-2). In other words, a diamine having a group represented by the following formula (Q-1) or the following formula (q-2) (hereinafter also referred to as ''specific diamine') is used. They may be used alone or in combination of two or more. Used in combination.

x—R6 (Q-1) 19- 200821372 (式中,X1 爲單鍵、-0-、-CO-、-COO-、-OCO-、-NHCO·、 -CONH-、-S-或伸芳基,R6是碳數爲l〇〜20的烷基、碳數 爲4〜40的具有脂環式骨架的1價有機基團或者碳數爲6 〜20的含氟原子的1價有機基團)。 X2- R7- (Q·2) (式中,X2 爲單鍵、-0-、-CO-、-COO-、-OCO·、-NHCO-、 -CONH-、-S-或伸芳基,R7是碳數爲4〜40的具有脂環式 骨架的2價有機基團)。 上述式(Q — 1)中,作爲R6表示的碳數爲10〜20的烷 基,可以舉例如正癸基、正十二烷基、正十五烷基、正十 六烷基、正十八烷基、正二十烷基等。另外,作爲上述式 (Q - 1)的R6和上述式(Q — 2)中的R7表示的碳數爲4〜40 的具有脂環式骨架的有機基團,可以舉例如具有來源於環 丁烷、環戊烷、環己烷、環癸烷等環烷的脂環式骨架的基 φ 團;具有膽甾醇、膽甾烷醇等甾體骨架的基團;具有降冰 片烯、金剛烷等橋環式骨架的基團等。其中,特佳爲具有 甾體骨架的基團。具有上述脂環式骨架的有機基團還可以 是被鹵素原子,較佳爲氟原子或氟代烷基,較佳爲三氟甲 基取代的基團。 此外,作爲上述式(Q - 1)的R6表示的碳數爲6〜20的 含氟原子的基團,可以舉例如正己基、正辛基 '正癸基等 碳數爲6以上的直鏈烷基;環己基、環辛基等碳數爲6以 上的脂環式烴基;苯基、聯苯基等碳數爲6以上的芳香族 -20- 200821372 烴基等有機基團的氫原子部分或全部被氟原子或三氟甲基 等氟代烷基取代的基團。 另外,上述式(Q— 1)的X1和上述式(Q— 2)的X2爲單 鍵、-0-、-CO-、-COO-、-OCO-、_NHCO_、-CON Η- ' -S-或者伸芳基。作爲伸芳基,可以舉例如伸苯基、伸甲苯基、 伸聯苯基、伸萘基等。其中,特佳爲-〇-、-COO-、-OCO- 表示的基團。作爲具有上述式(Q - 1)表示的基團的二胺的 具體例子,較佳的可以舉出十二烷氧基-2,4-二胺基苯、十 五烷氧基-2,4-二胺基苯、十六烷氧基-2,4-二胺基苯、十八 烷氧基-2,4-二胺基苯、下述式(9)〜(13)表示的化合物。x—R6 (Q-1) 19- 200821372 (wherein X1 is a single bond, -0-, -CO-, -COO-, -OCO-, -NHCO·, -CONH-, -S- or 延芳And R6 is an alkyl group having a carbon number of from 10 to 20, a monovalent organic group having an alicyclic skeleton having a carbon number of 4 to 40, or a monovalent organic group having a fluorine atom having a carbon number of 6 to 20. ). X2- R7- (Q·2) (wherein X2 is a single bond, -0-, -CO-, -COO-, -OCO·, -NHCO-, -CONH-, -S- or an aryl group, R7 is a divalent organic group having an alicyclic skeleton having a carbon number of 4 to 40). In the above formula (Q-1), the alkyl group having 10 to 20 carbon atoms represented by R6 may, for example, be n-decyl, n-dodecyl, n-pentadecyl, n-hexadecyl or n. Octaalkyl, n-icosyl, and the like. In addition, as the organic group having an alicyclic skeleton having 4 to 40 carbon atoms represented by R6 of the above formula (Q-1) and R7 in the above formula (Q-2), for example, a group φ group of an alicyclic skeleton of a cycloalkane such as an alkane, a cyclopentane, a cyclohexane or a cyclodecane; a group having a steroid skeleton such as cholesterol or cholestyl alcohol; having a norbornene, adamantane, or the like a group of a bridge-ring skeleton, and the like. Among them, a group having a steroid skeleton is particularly preferred. The organic group having the above alicyclic skeleton may also be a group substituted by a halogen atom, preferably a fluorine atom or a fluoroalkyl group, preferably a trifluoromethyl group. In addition, the fluorine atom-containing group having 6 to 20 carbon atoms represented by R6 in the above formula (Q-1) may, for example, be a straight chain having 6 or more carbon atoms such as n-hexyl or n-octyl-n-decyl group. An alkyl group; an alicyclic hydrocarbon group having 6 or more carbon atoms such as a cyclohexyl group or a cyclooctyl group; and a hydrogen atom portion of an organic group such as a hydrocarbon group having a carbon number of 6 or more such as a phenyl group or a biphenyl group; All groups substituted by a fluorine atom or a fluoroalkyl group such as a trifluoromethyl group. Further, X1 of the above formula (Q-1) and X2 of the above formula (Q-2) are a single bond, -0-, -CO-, -COO-, -OCO-, _NHCO_, -CON Η- '-S - Or stretch the base. Examples of the aryl group include a phenyl group, a tolyl group, a biphenyl group, a naphthyl group and the like. Among them, particularly preferred are groups represented by -〇-, -COO-, and -OCO-. Specific examples of the diamine having a group represented by the above formula (Q-1) include dodecyloxy-2,4-diaminobenzene and pentadecyloxy-2,4. -diaminobenzene, hexadecyloxy-2,4-diaminobenzene, octadecyloxy-2,4-diaminobenzene, a compound represented by the following formulas (9) to (13).

(11)(11)

(13) 另外,作爲具有上述式一 2)表示的基團的二胺的具 200821372(13) Further, as a diamine having a group represented by the above formula (2), 200821372

體例子,較佳爲可以舉出下述式(14)〜(16)表示的二胺As a typical example, preferred are diamines represented by the following formulas (14) to (16).

其中,作爲特佳的,可以舉出上述式(9)、(11)、(13)、 (14)表示的化合物。 特定二胺相對於全部二胺量的使用比率,隨著所要使 其表現的預傾角的大小而不同,對於TN型、STN型液晶 顯示元件的情況,較佳爲0〜5莫耳%,對於垂直配向型液 晶顯示元件的情況,較佳爲5〜1 00莫耳%。 <聚醯胺酸的合成> 供給聚醯胺酸合成反應的四羧酸二酸酐與二胺的使用 比率,較佳爲相對於1當量二胺的胺基,使四羧酸二酸酐 的酸酐基爲〇·2〜2當量的比率,更佳爲使其爲〇3〜12當 量的比率。 聚醯fee酸的合成反應,在有機溶劑中,較佳爲於_ 2 〇 °c 〜l5〇°C、更佳爲於0〜100°C的溫度條件下進行。 m裏’作爲有機溶劑’只要能夠溶解合成的聚醯胺酸, -22- 200821372 則對其沒有特別的限制,可以例示例如^甲基-2_吡咯院 酮、N,N•二甲基乙醯胺、N,N-二甲基甲醯胺、3_丁氧基_N,N-一甲基丙酿肢、3 -甲氧基-N,N -一甲基丙醯胺、3_己氧基 -N,N-二甲基丙醯胺等醯胺類溶劑、二甲基亞颯、r_丁內 酯、四甲基脲、六甲基磷醯三胺等非質子極性溶劑;間甲 酚、二甲苯酚、苯酚、鹵代苯酚等酚類溶劑。此外,有機 溶劑的用量(ct)通常較佳爲使四羧酸二酸酐和二胺化合物 的總量(β)相對於反應溶液的總量(α+β)爲重量% 的量。 另外’在不使生成的聚醯胺酸析出的範圍內,上述有 機溶劑中還可以倂用聚醯胺酸的不良溶劑(poor solvent)之 醇類、酮類、酯類、醚類、鹵代烴類、烴類等。作爲這種 不良溶劑的具體例子,可以舉例如甲醇、乙醇、異丙醇、 環己醇、4-羥基-4-甲基-2-戊酮、乙二醇、丙二醇、1,4-丁 二醇、三甘醇、乙二醇單甲醚、乳酸乙酯、乳酸丁酯、丙 0 酮、甲基乙基酮、甲基異丁基酮、環己酮、醋酸甲酯、醋 酸乙酯、醋酸丁酯、甲氧基丙酸甲酯、乙氧基丙酸乙酯、 草酸二乙酯、丙二酸二乙酯、二乙基醚、乙二醇甲醚、乙 二醇乙醚、乙二醇正丙醚、乙二醇異丙醚、乙二醇正丁醚、 乙二醇二甲基醚、乙二醇乙醚乙酸酯、二甘醇二甲醚、二 甘醇二乙醚、二甘醇單甲.醚、二甘醇單乙醚、二甘醇單甲 醚乙酸酯、二甘醇單乙醚乙酸酯、四氫呋喃、二氯甲烷、 1,2-二氯乙烷、1,4-二氯丁烷、三氯乙烷、氯苯、鄰二氯苯、 己烷、庚烷、辛烷、苯、甲苯、二甲苯、二異丁基酮、丙 -23- 200821372 酸異戊酯、異丁酸異戊酯、.二異戊基醚等。 如上述般進行’能得到溶解聚醯胺酸而形成的反應溶 液。然後,將該反應溶液注入到大量的不良溶劑中,得到 析出物’通過減壓下乾燥該析出物或者用蒸發器將反應溶 液減壓蒸餾去除,從而能得到聚醯胺酸。並且,.使該聚醯 胺酸再次溶解於有機溶劑中,然後通過進行一次或者數次 用不良溶劑使其析出或用蒸發器將其減壓蒸餾去除的製 程,可以精製聚醯胺酸。 ® <脫水閉環反應> ° 本發明液晶配向劑中的聚醯亞胺可以通過將上述聚醯 胺酸的一部分或全部脫水閉環而合成。 聚醯胺酸的脫水閉環可以(〇通過加熱聚醯胺酸的方 法,或者(π)通過將聚醯胺酸溶解於有機溶劑中,向該溶液 中加入脫水劑和脫水閉環催化劑並根據需要加熱的方法而 進行。 I 上述⑴的加熱聚醯胺酸的方法中的反應溫度,較佳爲 50〜2 00 °C,更佳爲60〜170 °C。當反應溫度不足50 °C時, 則脫水閉環反應不能進行完全,如果反應溫度超過200 °C, 則會出現所得醯亞胺化聚合物的分子量下降的情況。 另一方面,在上述(ii)的在聚醯胺酸溶液中添加脫水劑 和脫水閉環催化劑的方法中,作爲脫水劑,可以使用例如 醋酸酐、丙酸酐、三氟乙酸酐等酸酐。脫水劑的用量,根 據所需醯亞胺化率而定,較佳爲相對於1莫耳聚醯胺酸的 重複單元,爲0.0 1〜2 0莫耳。另外,作爲脫水閉環催化劑, -24- 200821372 可以使用例如吡啶、三甲吡啶、二甲基吡啶、三乙胺等3 級胺。但是,並不局限於這些。脫水閉環催化劑的用量, 相對於1莫耳所用脫水劑,較佳爲0.0 1〜1 0莫耳。上述脫 水劑、脫水閉環催化劑的用量越多,則可使醯亞胺化率越 高。此外,作爲脫水閉環反應中使用的有機溶劑,可以舉 出作爲聚醯胺酸合成中所用溶劑而例示的有機溶劑。並 且,脫水閉環反應的反應溫度較佳爲0〜180°c,更佳爲1〇 〜1 5 0 °c。此外,通過對如此得到的反應溶液進行與聚醯胺 ® 酸精之製方法同樣的操作,可以精製所得之特定聚合物。 本發明中所用的聚醯亞胺係全部重複單元中具有醯亞 胺環的重複單元的比率(以下,也稱爲“醯亞胺化率”)爲 40莫耳%以上,較佳爲50莫耳%以上。通過使用醯亞胺化 率爲4 0莫耳%以上的聚合物,可以獲得能夠形成殘像消除 時間短的液晶配向膜的液晶配向劑。醯亞胺化率可以通過 以下方法獲得。 _ [醯亞胺化聚合物的醯亞胺化率測定方法] 在將醯亞胺化聚合物在室溫下減壓乾燥之後,使其溶 解於氖化二甲基亞礪,將四甲基矽烷作爲基準物質在室溫 下測定1H-NMR,可以通過下述式(ii)獲得。 醯亞胺化率 α )xl00..........--(ii) A1 :來源於NH基之質子的峰値面積(1〇ppm) A2 :來源於其他質子的峰値面積 α :聚合物的前驅物(聚醯胺酸)中,相對於一個NH基 質子的其他質子的個數比率。 -25- 200821372 <末端修飾型聚合物> 本發明中所用的特定聚合物還可以是進行了分子量調 節的末端修飾型聚合物。通過使用該末端修飾型聚合物, 可以在不損害本發明效果的前提下改善液晶配向劑的塗敷 特性等。這種末端修飾型聚合物可以通過在合成聚醯胺酸 時,向反應體系中加入一元酸酐、單胺化合物、單異氰酸 酯化合物等而合成。其中,作爲一元酸酐,可以舉例如馬 來酸酐、苯二甲酸酐、衣康酸酐、正癸基琥珀酸酐、正十 ® 二烷基琥珀酸酐、正十四烷基琥珀酸酐、正十六烷基琥珀 酸酐等。此外,作爲單胺化合物,可以舉例如苯胺、環己 胺、正丁胺、正'戊胺、正己胺、正庚胺、正辛胺、正壬胺、 正癸胺、正十一烷胺、正十二烷胺、正十三烷胺、正十四 院胺、正十五院胺、正十六院胺、正十七院胺、正十八院 胺、正二十院胺等。此外,作爲單異氰酸酯化合物,可以 舉例如異氰酸苯酯、異氰酸萘基酯等。 [溶液黏度] ® 使用於本發明的配向劑的聚合物,在成爲10 %的溶液 時,較佳爲具有 20〜800m Pa.s黏度,更佳爲具有 30〜 5 0 0 m P a · s 黏度。 另外,使用指定的溶劑,對於稀釋爲指定的固體成分 濃度的溶液,用E型旋轉黏度計在2 5它下測定聚合物的溶 液黏度(mPa«s)。 [液晶配向劑] 本發明的液晶配向劑通常是通過將上述特定化合物溶 -26 - 200821372 解含於有機溶劑中而構成。 調製本發明液晶配向劑時的溫度較佳爲0 °C〜2 0 0 °C, 更佳爲20°C〜60°C。 作爲構成本發明液晶配向劑的有機溶劑,可舉出作爲 用於聚醯胺酸的合成反應而例示的溶劑。另外,也可以適 當地選擇倂用作爲能夠在聚醯胺酸的合成反應時倂用的不 良溶劑所例示的不良溶劑。 本發明液晶配向劑中固體成分濃度係考慮黏性、揮發 • 性等而進行選擇,較佳爲1〜10重量%的範圍。換句話說, 將本發明液晶配向劑塗敷於基板表面,形成作、爲液晶配向 膜的塗膜,當固體成分濃度不足1重量%時,將導致該塗 膜的膜厚過小,從而不能得到良好的液晶配向膜,當固體 成分濃度超過10重量%時,將導致塗膜膜厚過厚,從而不 能得到良好的液晶配向膜,並且,液晶配向劑的黏性增大, 塗敷特性變差。 另外,特佳的固體成分濃度的範圍,會因於基板塗敷 ® 液晶配向劑時所使用的方法而不同。例如,使用旋塗法的 場合,特佳爲1.5〜4.5重量%的範圍。使用印刷法的場合, 固體成分濃度爲3〜9重量%的範圍,依此,特佳爲將溶液 黏度成爲12〜5〇HiPa^s的範圍。使用噴墨印刷法的場合, 固體成分濃度爲1〜5重量%範圍,特佳爲溶液黏度3〜 15mPa«s的範圍。 作爲構成本發明液晶配向劑的有機溶劑,例如,可以 舉出1-甲基-2-吡咯烷酮、r-丁內酯、r-丁內醯胺、n,n- -27- 200821372 二甲基甲醯胺、N,N-二甲基乙醯胺、4-羥基-4-甲基-2-戊 酮、乙二醇單甲醚、乳酸丁酯、乙酸丁酯、甲氧基丙酸甲 酯、乙氧基丙酸乙酯、乙二醇甲醚、乙二醇乙醚、乙二醇 正丙醚、乙二醇異丙醚、乙二醇正丁醚(丁基溶纖劑)、乙 二醇二甲基醚、乙二醇乙醚乙酸酯、二甘醇二甲醚、二甘 醇二乙醚、二甘醇單甲醚、二甘醇單乙醚、二甘醇單甲醚 乙酸酯、.二甘醇單乙醚乙酸酯、3-丁氧基-N,N-二甲基丙醯 胺、3-甲氧基·Ν,Ν-二甲基丙醯胺、3-己氧基-N,N-二甲基丙 醯胺、二異丁基酮(DIB K)、丙酸異戊酯、異丁酸異戊酯、 二異戊基醚等。它們既可以單獨使用,也可以混合兩種以 上使用。其中,3-丁氧基-N,N-二甲基丙醯胺、3-甲氧基-N,N-二甲基丙醯胺、3-己氧基-N,N-二甲基丙醯胺係由於顯示良 好的印刷性而特佳。 本發明的液晶配向劑在不損害目的物性的範圍內,從 提高對基板表面接著性的角度考慮,還可以含有含官能性 矽烷的化合物、環氧基化合物。作爲這種含官能性矽烷的 化合物,可以舉出例如3-胺基丙基三甲氧基矽烷、3-胺基 丙基三乙氧基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙 基三乙氧基矽烷、N-(2-胺基乙基)-3·胺基丙基三甲氧基矽 烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、3-脲 基丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、N-乙氧 羰基-3-胺基丙基三甲氧基矽烷、N-乙氧羰基-3-胺基丙基三 乙氧基矽烷、N-三乙氧基矽烷基丙基三伸乙基三胺、N-三 甲氧基矽烷基丙基三伸乙基三胺、10-三甲氧基矽烷-1,4,7_ -28- 200821372 三氮雜癸烷、10-三乙氧基矽烷基-1,4,7-三氮雜癸烷、9-三 甲氧基矽烷基-3,6-二氮雜壬基乙酸酯、9-三乙氧基矽烷基 -3,6-二氮雜壬基乙酸酯、N-苄基-3-胺基丙基三甲氧基矽 烷、N_苄基-3-胺基丙基三乙氧基矽烷、N-苯基-3-胺基丙基 三甲氧基矽烷、N-苯基-3-胺基丙基三乙氧基矽烷、N-二(氧 伸乙基)_3-胺基丙基三甲氧基矽烷、N-二(氧伸乙基)-3-胺 基丙基三乙氧基矽烷等。作爲這種環氧基化合物,可以舉 例如乙二醇二縮水甘油醚、聚乙二醇二縮水甘油醚、丙二 ® 醇二縮水甘油醚、三丙二醇二縮水甘油醚、聚丙二醇二縮 水甘油醚、新戊二醇二縮水甘油醚、1,6-己二醇二縮水甘 油醚、甘油二縮水甘油醚、2,2-二溴新戊二醇二縮水甘油 醚、1,3,5,6-四縮水甘油基-2,4-己二醇、Ν,Ν,Ν'Ν’-四縮水 甘油基-間苯二甲胺、1,3-二(N,N-二縮水甘油基胺基甲基) 環己烷、N,N,N’,N’-四縮水甘油基-4,4’-二胺基二苯基甲 烷、3-(N-烯丙基-N-縮水甘油基)胺基丙基三甲氧基砂院、 3-(N,N-二縮水甘油基)胺基丙基三甲氧基矽烷、N,N-二縮 ® 水甘油基-苄胺、Ν,Ν·二縮水甘油基-胺基甲基環己院等。 這些含官能性矽烷化合物和含環氧基化合物的配合比 例,相對於1 〇〇重量份聚合物,較佳爲40重量份以下,更 佳爲〇 . 1〜3 0重量份。 <液晶顯示元件> 用本發明液晶配向劑製得的液晶顯示元件、,可以通過 例如以下的方法製造。 (1)通過平版印刷法、旋塗法或者噴墨印刷法,將本發 -29- 200821372 明的液晶配向劑塗敷在設有形成圖案的透明導電膜的基板 之一面上,接著,通過加熱塗敷面形成塗膜。這裏’作爲 基板,可以使用例如浮法玻璃、鈉鈣玻璃等玻璃;聚對苯 二甲酸乙二醇酯、聚對苯二甲酸丁二醇酯、聚醚颯、聚碳 酸酯、脂環式聚烯烴等由塑膠形成的透明基板。作爲基板 之一面上所設置的透明導電膜,可以使用由氧化錫(Sn02) 形成的NES A膜(美國PPG公司註冊商標)、由氧化銦一氧 化錫(ln203 — Sn02)形成的ITO膜等,這些透明導電膜圖案 的形成採用光蝕刻法或預先使用遮罩的方法。在液晶配向 劑的塗敷時,爲了進一步改善基板表面和透明導電膜與塗 膜的接著性,還可以在基板的該表面上預先塗敷含官能性 矽烷的化合物、含官能性鈦的化合物等。塗敷液晶配向劑 後,以防止已塗敷的配向劑的液體流下等爲目的,較佳爲 實施預備加熱(預焙燒)。預焙燒(pre-bake)的溫度較佳爲30 〜300 °C,更佳爲40〜2001:,特佳爲50〜150 °C。之後, 將溶劑完全除去,以將聚醯胺酸熱醯亞胺化爲目的,實施 焙燒製程(後焙燒(post-bake))。該焙燒(後焙燒)溫度較佳爲 80〜300 °C,更佳爲120〜250 °C。這樣,含聚醯胺酸的本 發明液晶配向劑,通過塗敷後除去有機溶劑,形成作爲液 晶配向膜的液晶配向膜。還可以通過進一步加熱使其進行 脫水閉環,形成進一步醯亞胺化的液晶配向膜。形成的液 晶配向膜的膜厚較佳爲〇 . 〇 〇 1〜1 μπι,更佳爲〇 . 〇 〇 5〜〇 . 5 μπι。 • (2)對所形成的塗膜面用纏有由例如尼龍、人造纖維、 棉花等纖維形成的布的輥進行以一定方向摩擦的打磨處 -3 0 - 200821372 理。藉此,將液晶分子的配向能賦予塗膜而成爲配向膜。 另外,對由本發明液晶配向劑形成的液晶配向膜,進行例 如日本特開平6 — 2223 66號公報或日本特開平6 — 28 1 9 3 7 號公報中所示,藉由部分地照射紫外線而使預傾角改變的 處理,或者進行如日本特開平5 — 1 07544號公報中所示, 進行在已實施打磨處理的液晶配向膜表面部分地形成阻劑 膜,以與先前打磨處理不同的方向進行打磨處理後除去阻 劑(resist)膜,使液晶配向膜的液晶配向能改變的處理,藉 ^ 此能夠改善液晶顯示元件的視野特性。 (3)製作2片如上述進行而形成液晶配向膜的基板,將 2片基板通過間隙(晶胞間隙)相對配置,使各自液晶配向膜 的打磨方向相互垂直或逆平行,將2塊基板之周邊部位用 密封劑貼合,向由基板表面和密封劑分割出的晶胞間隙內 注入充塡液晶,封閉注入孔,構成液晶胞。然後,藉由在 v 液晶胞的外表面,即構成液晶胞的各基板的另一側面上, 貼合偏光板,使其偏光方向與該基板一面上所形成的液晶 配向膜的打磨方向一致或者垂直,製得液晶顯示元件。這 裏,作爲密封劑,可以使用例如作爲固化劑和間隙物的含 氧化鋁球的環氧樹脂等。作爲液晶,可以舉出向列型液晶 和碟狀型液晶,其中較佳爲向列型液晶,可以使用例如希 夫氏鹼類液晶、氧化偶氮基類液晶、聯苯類液晶、苯基環 己烷類液晶、酯類液晶、三聯苯類液晶、聯苯基環己烷類 液晶、嘧啶類液晶、二氧陸圜類液晶、雙環辛烷類液晶、 立方烷類液晶等。此外,這些液晶中還可以添加例如氯化 -31- 200821372 胆甾醇、胆甾醇壬酸酯、胆甾醇碳酸酯等之胆甾型液晶和 以商品名“C-15”、“CB-15”(默克公司製)銷售的手性劑等而 進行使用。並且,還可以使用對癸氧基苯亞甲基·對胺基-2-甲基丁基肉桂酸酯等鐵電性液晶。另外,作爲液晶胞外表 面上貼合的偏光板,可以舉出將聚乙烯醇延伸配向同時吸 收碘所得的稱作爲Η膜的偏光膜夾在醋酸纖維保護膜中而 製成的偏光板或者Η膜自身製成的偏光板。 這裏,作爲密封劑,可以使用例如作爲固化劑和間隙 ^ 物的含氧化鋁球的環氧樹脂等。 作爲液晶,可以舉出向列型液晶和碟狀型液晶,其中 較佳爲向列型液晶,可以使用例如希夫氏鹼類液晶、氧化 偶氮基類液晶、聯苯類液晶、苯基環己烷類液晶、酯類液 晶、三聯苯類液晶、聯苯基環己烷類液晶、嘧啶類液晶、 二氧陸圜類液晶、雙環辛烷類液晶、立方烷類液晶等。此 外,這些液晶中還可以添加例如氯化胆甾醇、胆甾醇壬酸 酯、胆甾醇碳酸酯等之胆甾型液晶和以商品名“C-15”、 “CB-15”(默克公司製)銷售的手性劑等而進行使用。並且, 還可以使用對癸氧基苯亞甲基-對胺基-2-甲基丁基肉桂酸 酯等鐵電性液晶。 另外,作爲液晶胞外表面上貼合的偏光板,可以舉出 將聚乙烯醇延伸配向同時吸收碘所得的稱作爲Η膜的偏光 膜夾在醋酸纖維保護膜中而製成的偏光板或者Η膜自身製 成的偏光板。 【實施例】 -32- 200821372 以下,通過實施例對本發明進行更具體的說明,但是 本發明並不局限於這些實施例。 [印刷性評價] 準備在單面的整面上已形成ITO膜的127mm(D)X 1 27mm (W)x 1.1 mm (Η)的玻璃基板,將上述實驗中得到的液 晶配向劑以孔徑爲〇 · 2 μιη的微孔濾器過濾後,用液晶配向 膜塗敷用印刷機(日本寫真印刷株式會社製造,Angstromer S- 40 L)塗敷於該玻璃基板的透明電極面上。以已設定爲 ^ 80°C的加熱板密著式預備乾燥機進行乾燥,在200°C下焙 燒60分鐘,在附有ITO膜的玻璃基板上形成液晶配向膜。 以目視評估所得配向膜的不均勻。 [電壓保持率] 在60°C的環境下,在1 67毫秒的時間間隔內,給液晶 顯示元件施加5V的電壓,電壓施加時間爲60微秒,然後 測定從電壓解除至1 67毫秒後的電壓保持率。測定裝置使 用東陽科技(股)製的VHR-1。 ^ [殘影實驗] 製作如第1圖所示的具有ITO電極的晶胞。在室溫下, 向電極A施加24小時6.0V直流電壓,向電極B施加24 小時0.5 V直流電壓。釋放應力(stress)後,向電極A、B以 〇.IV的梯度施加〇·1〜5.0V直流電壓。通過各電壓下電極 A、Β的亮度差判斷殘影特性。當亮度差大時,殘影特性判 斷爲差。 <特定化合物的合成> -33- 200821372 合成例Among them, particularly preferred are compounds represented by the above formulas (9), (11), (13), and (14). The ratio of use of the specific diamine to the total amount of the diamine varies depending on the magnitude of the pretilt angle to be expressed, and in the case of the TN type or STN type liquid crystal display element, it is preferably 0 to 5 mol%. In the case of the vertical alignment type liquid crystal display element, it is preferably 5 to 100% by mole. <Synthesis of Polylysine> The use ratio of the tetracarboxylic dianhydride to the diamine supplied to the polyaminic acid synthesis reaction is preferably a tetracarboxylic dianhydride relative to the amine group of 1 equivalent of the diamine The acid anhydride group is a ratio of 〜 2 to 2 equivalents, more preferably a ratio of 〜 3 to 12 equivalents. The synthesis reaction of the polyfluorene Fee acid is preferably carried out in an organic solvent at a temperature of from _ 2 〇 ° c to 15 ° C, more preferably from 0 to 100 ° C. m is 'as an organic solvent' as long as it can dissolve the synthesized polyaminic acid, and -22-200821372 is not particularly limited, and examples thereof include methyl 2-pyrrolidone and N, N•dimethyl B. Indoleamine, N,N-dimethylformamide, 3-butoxy-N,N-methylpropane, 3 -methoxy-N,N-methylpropanamide, 3_ An aprotic solvent such as decylamine such as hexyloxy-N,N-dimethylpropionamide; dimethyl hydrazine, r-butyrolactone, tetramethylurea or hexamethylphosphonium triamine; Phenolic solvents such as m-cresol, xylenol, phenol, and halogenated phenol. Further, the amount (ct) of the organic solvent is usually preferably an amount such that the total amount (β) of the tetracarboxylic acid dianhydride and the diamine compound is % by weight relative to the total amount (α + β) of the reaction solution. Further, in the above-mentioned organic solvent, alcohols, ketones, esters, ethers, halogenated groups of a poor solvent of polyglycine may be used in the range in which the produced polyamine acid is not precipitated. Hydrocarbons, hydrocarbons, etc. Specific examples of such a poor solvent include methanol, ethanol, isopropanol, cyclohexanol, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol, propylene glycol, and 1,4-butane. Alcohol, triethylene glycol, ethylene glycol monomethyl ether, ethyl lactate, butyl lactate, propanone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, methyl acetate, ethyl acetate, Butyl acetate, methyl methoxypropionate, ethyl ethoxy propionate, diethyl oxalate, diethyl malonate, diethyl ether, ethylene glycol methyl ether, ethylene glycol ether, ethylene Alcohol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether, ethylene glycol ethyl ether acetate, diglyme, diethylene glycol diethyl ether, diethylene glycol Methyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, tetrahydrofuran, dichloromethane, 1,2-dichloroethane, 1,4-dichloro Butane, trichloroethane, chlorobenzene, o-dichlorobenzene, hexane, heptane, octane, benzene, toluene, xylene, diisobutyl ketone, propane-23-200821372 isovalerate, isobutyl Isoamyl acid, diisoamyl Ether, etc. The reaction solution formed by dissolving polylysine was obtained as described above. Then, the reaction solution is poured into a large amount of a poor solvent to obtain a precipitate. The precipitate is dried by a reduced pressure or the reaction solution is distilled off under reduced pressure with an evaporator to obtain a polyamine. Further, the polylysine is re-dissolved in an organic solvent, and then the polypergic acid can be purified by performing a process of precipitating with a poor solvent once or several times or by vacuum distillation using an evaporator. ® <Dehydration ring closure reaction> The polyimine in the liquid crystal alignment agent of the present invention can be synthesized by dehydration ring closure of a part or all of the above polyamic acid. The dehydration ring closure of the poly-proline may be carried out by heating the poly-proline, or (π) by dissolving the poly-proline in an organic solvent, adding a dehydrating agent and a dehydration ring-closing catalyst to the solution and heating as needed. The reaction temperature in the method for heating poly-proline in the above (1) is preferably 50 to 200 ° C, more preferably 60 to 170 ° C. When the reaction temperature is less than 50 ° C, The dehydration ring-closure reaction cannot be completed completely. If the reaction temperature exceeds 200 ° C, the molecular weight of the obtained ruthenium-imided polymer may decrease. On the other hand, the dehydration is added to the poly-proline solution in the above (ii). In the method of the agent and the dehydration ring-closing catalyst, as the dehydrating agent, an acid anhydride such as acetic anhydride, propionic anhydride or trifluoroacetic anhydride can be used. The amount of the dehydrating agent is determined according to the desired hydrazine imidization ratio, preferably relative to The repeating unit of 1 mole polyproline is 0.01 to 2.0 moles. In addition, as a dehydration ring-closing catalyst, -24-200821372 can be used, for example, pyridine, trimethylpyridine, lutidine, triethylamine, etc. amine However, it is not limited to these. The amount of the dehydration ring-closing catalyst is preferably 0.01 to 10 moles per mol of the dehydrating agent used. The more the dehydrating agent and the dehydration ring-closing catalyst are used, the more In addition, the organic solvent used for the dehydration ring-closure reaction is exemplified as the organic solvent used for the synthesis of the poly-proline, and the reaction temperature of the dehydration ring-closure reaction is preferably 0. ~180°c, more preferably 1〇1 to 150°C. Further, the specific polymer obtained can be purified by performing the same operation as the method for producing the polyamide amine acid by the reaction solution thus obtained. The ratio of the repeating unit having a quinone ring in all the repeating units used in the invention (hereinafter, also referred to as "deuterated imidization ratio") is 40 mol% or more, preferably 50 mol. By using a polymer having a ruthenium iodide ratio of 40% by mole or more, a liquid crystal alignment agent capable of forming a liquid crystal alignment film having a short afterimage erasing time can be obtained. The yield of ruthenium can be obtained by the following method. _ [Method for Measuring the Amidation Rate of the Iridium Amineated Polymer] After drying the ruthenium iodide polymer under reduced pressure at room temperature, it is dissolved in deuterated dimethyl hydrazine, and tetramethyl decane is added. The 1H-NMR measurement at room temperature as a reference substance can be obtained by the following formula (ii). The oxime imidization ratio α)xl00..........--(ii) A1: from NH The peak area of the protons (1〇ppm) A2: the area of the peaks derived from other protons α: the ratio of the number of other protons in the precursor of the polymer (polyproline) relative to one NH proton . -25-200821372 <Terminal-modified polymer> The specific polymer used in the present invention may also be a terminal-modified polymer having a molecular weight adjustment. By using the terminal-modified polymer, the coating property and the like of the liquid crystal alignment agent can be improved without impairing the effects of the present invention. Such a terminally modified polymer can be synthesized by adding a monobasic acid anhydride, a monoamine compound, a monoisocyanate compound or the like to the reaction system in the synthesis of polyamic acid. Among them, as the monobasic acid anhydride, for example, maleic anhydride, phthalic anhydride, itaconic anhydride, n-decyl succinic anhydride, n-dodecyl succinic anhydride, n-tetradecyl succinic anhydride, n-hexadecyl group Succinic anhydride and the like. Further, examples of the monoamine compound include aniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine, n-decylamine, n-decylamine, n-undecylamine, and the like. N-dodecylamine, n-tridecylamine, n-tetradecylamine, n-five-family amine, hexadecanolamine, n-xylamine, n-octa-amine, and hexaamine. Further, as the monoisocyanate compound, for example, phenyl isocyanate, naphthyl isocyanate or the like can be exemplified. [Solid viscosity] ® The polymer used in the alignment agent of the present invention preferably has a viscosity of 20 to 800 mPa.s, more preferably 30 to 500 m P a · s when it is a 10% solution. Viscosity. Further, using a specified solvent, the solution viscosity (mPa «s) of the polymer was measured under an E-type rotational viscometer for a solution diluted to a specified solid concentration. [Liquid Crystal Aligning Agent] The liquid crystal alignment agent of the present invention is usually constituted by dissolving the above specific compound -26 - 200821372 in an organic solvent. The temperature at which the liquid crystal alignment agent of the present invention is prepared is preferably from 0 ° C to 200 ° C, more preferably from 20 ° C to 60 ° C. The organic solvent constituting the liquid crystal alignment agent of the present invention may, for example, be a solvent exemplified as a synthesis reaction for polyglycine. Further, it is also possible to appropriately select a poor solvent exemplified as a poor solvent which can be used in the synthesis reaction of polyproline. The solid content concentration in the liquid crystal alignment agent of the present invention is selected in consideration of viscosity, volatilization, etc., and is preferably in the range of 1 to 10% by weight. In other words, the liquid crystal alignment agent of the present invention is applied to the surface of the substrate to form a coating film which is a liquid crystal alignment film. When the solid content concentration is less than 1% by weight, the film thickness of the coating film is too small to be obtained. A good liquid crystal alignment film, when the solid content concentration exceeds 10% by weight, causes the film thickness of the coating film to be too thick, so that a good liquid crystal alignment film cannot be obtained, and the viscosity of the liquid crystal alignment agent is increased, and the coating property is deteriorated. . In addition, the range of the particularly preferable solid content concentration differs depending on the method used for the substrate coating of the liquid crystal alignment agent. For example, in the case of using a spin coating method, it is particularly preferably in the range of 1.5 to 4.5% by weight. When the printing method is used, the solid content concentration is in the range of 3 to 9 % by weight, and particularly preferably, the solution viscosity is in the range of 12 to 5 Å HiPa s. When the inkjet printing method is used, the solid content concentration is in the range of 1 to 5 wt%, and particularly preferably in the range of 3 to 15 mPa «s of the solution viscosity. Examples of the organic solvent constituting the liquid crystal alignment agent of the present invention include 1-methyl-2-pyrrolidone, r-butyrolactone, r-butylide, n, n--27-200821372 dimethyl group. Indoleamine, N,N-dimethylacetamide, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol monomethyl ether, butyl lactate, butyl acetate, methyl methoxypropionate Ethyl ethoxypropionate, ethylene glycol methyl ether, ethylene glycol ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether (butyl cellosolve), ethylene glycol dimethyl Ether, ethylene glycol ethyl ether acetate, diglyme, diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol Monoethyl ether acetate, 3-butoxy-N,N-dimethylpropanamide, 3-methoxyindole, hydrazine-dimethylpropanamide, 3-hexyloxy-N,N- Dimethylpropionamide, diisobutyl ketone (DIB K), isoamyl propionate, isoamyl isobutyrate, diisoamyl ether, and the like. They can be used alone or in combination of two or more. Among them, 3-butoxy-N,N-dimethylpropanamide, 3-methoxy-N,N-dimethylpropanamide, 3-hexyloxy-N,N-dimethylpropyl The guanamine is particularly excellent in exhibiting good printability. The liquid crystal alignment agent of the present invention may further contain a functional decane-containing compound or an epoxy compound from the viewpoint of improving the adhesion to the surface of the substrate within a range not impairing the physical properties of the object. As such a functional decane-containing compound, for example, 3-aminopropyltrimethoxydecane, 3-aminopropyltriethoxydecane, 2-aminopropyltrimethoxydecane, 2- Aminopropyltriethoxydecane, N-(2-aminoethyl)-3.aminopropyltrimethoxydecane, N-(2-aminoethyl)-3-aminopropylmethyl Dimethoxyoxane, 3-ureidopropyltrimethoxydecane, 3-ureidopropyltriethoxydecane, N-ethoxycarbonyl-3-aminopropyltrimethoxydecane, N-B Oxycarbonyl-3-aminopropyltriethoxydecane, N-triethoxydecylpropyltriethylethylamine, N-trimethoxydecylpropyltriethylamine, 10- Trimethoxydecane-1,4,7_-28- 200821372 Triazadecane, 10-triethoxydecyl-1,4,7-triazadecane, 9-trimethoxydecyl-3 , 6-diazaindolyl acetate, 9-triethoxydecyl-3,6-diazaindolyl acetate, N-benzyl-3-aminopropyltrimethoxydecane, N-benzyl-3-aminopropyltriethoxydecane, N-phenyl-3-aminopropyltrimethoxydecane, N-phenyl-3-aminopropyltriethoxysulfonium , N- bis (ethyl extend oxygen) _3- aminopropyl trimethoxy Silane, N- bis (oxo extending ethyl) 3-amine propyl triethoxy silane-yl and the like. Examples of such an epoxy compound include ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, and polypropylene glycol diglycidyl ether. , neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromoneopentyl glycol diglycidyl ether, 1,3,5,6 -tetraglycidyl-2,4-hexanediol, hydrazine, hydrazine, Ν'Ν'-tetraglycidyl-m-xylylenediamine, 1,3-bis(N,N-diglycidylamino) Methyl) cyclohexane, N, N, N', N'-tetraglycidyl-4,4'-diaminodiphenylmethane, 3-(N-allyl-N-glycidyl) Aminopropyltrimethoxy sand, 3-(N,N-diglycidyl)aminopropyltrimethoxydecane, N,N-disubstituted® glyceryl-benzylamine, hydrazine, hydrazine Glycidyl-aminomethylcyclohexanthes and the like. The compounding ratio of the functional decane-containing compound and the epoxy group-containing compound is preferably 40 parts by weight or less, more preferably 1 to 30 parts by weight, per part by weight of the polymer. <Liquid crystal display element> The liquid crystal display element obtained by using the liquid crystal alignment agent of the present invention can be produced, for example, by the following method. (1) Applying the liquid crystal alignment agent of the present invention to a surface of a substrate provided with a patterned transparent conductive film by a lithography method, a spin coating method, or an inkjet printing method, followed by heating The coated surface forms a coating film. Here, 'as a substrate, glass such as float glass or soda lime glass; polyethylene terephthalate, polybutylene terephthalate, polyether oxime, polycarbonate, alicyclic poly A transparent substrate made of plastic such as olefin. As the transparent conductive film provided on one surface of the substrate, a NES A film (registered trademark of PPG, USA) formed of tin oxide (SnO 2 ), an ITO film formed of indium tin oxide (ln203 — SnO 2 ), or the like can be used. These transparent conductive film patterns are formed by photolithography or a method of using a mask in advance. In the application of the liquid crystal alignment agent, in order to further improve the adhesion between the surface of the substrate and the transparent conductive film and the coating film, a functional decane-containing compound, a functional titanium-containing compound, or the like may be applied to the surface of the substrate in advance. . After the application of the liquid crystal alignment agent, it is preferred to carry out preliminary heating (pre-baking) for the purpose of preventing the liquid of the applied alignment agent from flowing down. The pre-bake temperature is preferably from 30 to 300 ° C, more preferably from 40 to 2001: and particularly preferably from 50 to 150 ° C. Thereafter, the solvent was completely removed to carry out a calcination process (post-bake) for the purpose of heat-imidating the polyglycolic acid. The calcination (post-baking) temperature is preferably from 80 to 300 ° C, more preferably from 120 to 250 ° C. Thus, the liquid crystal alignment agent of the present invention containing polyglycolic acid is subjected to coating to remove the organic solvent to form a liquid crystal alignment film as a liquid crystal alignment film. It is also possible to carry out dehydration ring closure by further heating to form a further yttrium-imided liquid crystal alignment film. The film thickness of the liquid crystal alignment film to be formed is preferably 〇 〇 〇 1 to 1 μπι, more preferably 〇 . 〇 〇 5 〇 . 5 μπι. (2) Grinding the formed coating film surface with a roller wrapped with a cloth made of fibers such as nylon, rayon, cotton, etc., rubbing in a certain direction -3 0 - 200821372. Thereby, the alignment of the liquid crystal molecules can be imparted to the coating film to form an alignment film. Further, the liquid crystal alignment film formed of the liquid crystal alignment agent of the present invention is partially irradiated with ultraviolet rays as shown in, for example, Japanese Laid-Open Patent Publication No. Hei. No. Hei. The process of changing the pretilt angle, or performing the process of partially forming a resist film on the surface of the liquid crystal alignment film which has been subjected to the rubbing treatment, as shown in Japanese Patent Laid-Open Publication No. Hei No. Hei No. Hei No. Hei. After the treatment, the resist film is removed, and the liquid crystal alignment of the liquid crystal alignment film can be changed, whereby the visual field characteristics of the liquid crystal display element can be improved. (3) Two substrates in which the liquid crystal alignment film was formed as described above were produced, and the two substrates were arranged to face each other through the gap (cell gap) so that the polishing directions of the respective liquid crystal alignment films were perpendicular or antiparallel to each other, and the two substrates were The peripheral portion is bonded with a sealant, and a liquid crystal is filled into the cell gap which is separated from the surface of the substrate and the sealant, and the injection hole is closed to constitute a liquid crystal cell. Then, the polarizing plate is bonded to the outer surface of the v liquid crystal cell, that is, the other side surface of each of the substrates constituting the liquid crystal cell, so that the polarizing direction thereof coincides with the rubbing direction of the liquid crystal alignment film formed on one side of the substrate or Vertically, a liquid crystal display element is produced. Here, as the sealant, for example, an alumina ball-containing epoxy resin as a curing agent and a spacer may be used. Examples of the liquid crystal include a nematic liquid crystal and a disk-shaped liquid crystal. Among them, a nematic liquid crystal is preferable, and for example, a Schiff base liquid crystal, an oxidized azo liquid crystal, a biphenyl liquid crystal, or a phenyl ring can be used. A hexane liquid crystal, an ester liquid crystal, a terphenyl liquid crystal, a biphenylcyclohexane liquid crystal, a pyrimidine liquid crystal, a dioxane liquid crystal, a bicyclooctane liquid crystal, or a cuba liquid crystal. Further, cholesteric liquid crystals such as chlorinated-31-200821372 cholesterol, cholesteryl phthalate, cholesteryl carbonate, and the like, and trade names "C-15" and "CB-15" may be added to these liquid crystals. The chiral agent sold by Merck & Co., Ltd. is used. Further, a ferroelectric liquid crystal such as p-methoxybenzylidene-p-amino-2-methylbutylcinnamate may also be used. In addition, as a polarizing plate to be bonded to the outer surface of the liquid crystal, a polarizing plate or a crucible formed by sandwiching a polyvinyl alcohol and absorbing iodine, which is a bismuth film, is sandwiched between a protective film of cellulose acetate. A polarizing plate made of the film itself. Here, as the sealant, for example, an alumina ball-containing epoxy resin or the like as a curing agent and a gap can be used. Examples of the liquid crystal include a nematic liquid crystal and a disk-shaped liquid crystal. Among them, a nematic liquid crystal is preferable, and for example, a Schiff base liquid crystal, an oxidized azo liquid crystal, a biphenyl liquid crystal, or a phenyl ring can be used. A hexane liquid crystal, an ester liquid crystal, a terphenyl liquid crystal, a biphenyl cyclohexane liquid crystal, a pyrimidine liquid crystal, a dioxane liquid crystal, a bicyclooctane liquid crystal, a cuba liquid crystal, or the like. Further, cholesteric liquid crystals such as cholesteryl chloride, cholesteryl phthalate, and cholesteryl carbonate may be added to these liquid crystals, and the trade names "C-15" and "CB-15" (manufactured by Merck & Co., Inc.) may be added. The chiral agent sold, etc. is used. Further, a ferroelectric liquid crystal such as p-methoxybenzylidene-p-amino-2-methylbutylcinnamate may also be used. In addition, as a polarizing plate to be bonded to the outer surface of the liquid crystal, a polarizing plate or a crucible formed by sandwiching a polyvinyl alcohol and absorbing iodine, which is a bismuth film, is sandwiched between a protective film of cellulose acetate. A polarizing plate made of the film itself. [Embodiment] -32-200821372 Hereinafter, the present invention will be more specifically described by way of Examples, but the present invention is not limited to these Examples. [Printability Evaluation] A 127 mm (D) X 1 27 mm (W) x 1.1 mm (Η) glass substrate having an ITO film formed on the entire surface of one surface was prepared, and the liquid crystal alignment agent obtained in the above experiment was made to have a pore diameter of The filter was applied to a transparent electrode surface of the glass substrate by a liquid crystal alignment film coating printer (Angstromer S-40L, manufactured by Nippon Photo Printing Co., Ltd.). The film was dried by a hot plate-type preliminary pre-drying machine set at 280 ° C, and baked at 200 ° C for 60 minutes to form a liquid crystal alignment film on a glass substrate with an ITO film. The unevenness of the resulting alignment film was visually evaluated. [Voltage Retention Rate] In a temperature of 60 ° C, a voltage of 5 V was applied to the liquid crystal display element at a time interval of 167 msec, the voltage application time was 60 μsec, and then the voltage was released from the time of the voltage release to 167 ms. Voltage retention rate. The measuring device uses VHR-1 manufactured by Dongyang Technology Co., Ltd. ^ [Image Residual Experiment] A unit cell having an ITO electrode as shown in Fig. 1 was produced. At room temperature, a DC voltage of 6.0 V was applied to the electrode A for 24 hours, and a DC voltage of 0.5 V was applied to the electrode B for 24 hours. After the stress was released, a voltage of 〇·1 to 5.0 V DC was applied to the electrodes A and B in a gradient of 〇.IV. The image sticking characteristics were judged by the difference in luminance between the electrodes A and 各 at each voltage. When the luminance difference is large, the afterimage characteristic is judged to be poor. <Synthesis of Specific Compound> -33- 200821372 Synthesis Example

催化劑_catalyst_

(A — 1) 在氮氣環境下向5 00ml的四頸燒瓶中加入甲苯20ml、 催化劑之醋酸銷(11) 0 · 4 2 g (0 · 0 0 1 8 m 0 1)、3級丁基膦1 · 5 g (0.0 0 7 5 m ο 1),攪拌幾分鐘後,滴力口 4,4 ’ -二溴聯苯 2 9.3 g ( 0.0 9 4 m ο 1)的甲苯溶液1 〇 〇 m 1,進一步攪拌1 〇分鐘。 接著,力D入苯胺 18.3g(0.196mol)的甲苯溶液 200ml 後,再加入3級丁氧基鈉15.86g(0.165mol),加熱回流4 小畤使其反應。反應結束後,向容器中加入水,用二乙S 醚萃取。用硫酸鈉脫水後,濾除硫酸鈉,通過旋轉蒸發儀 除去溶劑。將粗產物通過氧化矽管柱層析法進行精製,得 到特定化合物(A — 1 ;)。 合成例2(A - 1) Toluene 20 ml of toluene in a 500 ml four-necked flask under nitrogen atmosphere, acetic acid pin (11) 0 · 4 2 g (0 · 0 0 1 8 m 0 1), butyl phosphine 1 · 5 g (0.0 0 7 5 m ο 1), after stirring for a few minutes, the 4,4 '-dibromobiphenyl 2 9.3 g ( 0.0 9 4 m ο 1) toluene solution 1 〇〇m 1 , further stir for 1 〇 minutes. Next, force D was added to a solution of 18.3 g (0.196 mol) of aniline in 200 ml of toluene, and then 15.86 g (0.165 mol) of sodium 3-butoxide was added thereto, and the mixture was heated under reflux for 4 hours to cause a reaction. After the reaction was completed, water was added to the vessel and extracted with diethyl ether. After dehydration with sodium sulfate, sodium sulfate was filtered off and the solvent was removed by rotary evaporator. The crude product was purified by hydrazine column chromatography to give a specific compound (A-1). Synthesis Example 2

(B—1) -34- ,200821372 在氮氣環境下向5〇〇ml的四頸燒瓶中加入甲苯2〇1111、 催化劑之醋酸鈀(n)0.42g(0.0018m〇l)、3 級丁基膦 1.5g(0.0075mol),攪拌幾分鐘後,滴力口 2,7-二溴芴 3 0.4g(0.094mol)的甲苯溶液100m卜進一步攬拌10分鐘。 接著,加入苯胺18.3g(0.196mol)的甲苯溶液200ml後,再 加入3級丁氧基鈉15.86g(0.165mol),加熱回流4小時使 其反應。反應結束後,向容器中加入水,用乙醚萃取。用 硫酸鈉脫水後,濾除硫酸鈉,通過旋轉蒸發儀除去溶劑。 ^ 將粗產物通過氧化矽管柱層析法進行精製,得到特定化合 物(B - 1)。 合成例3(B-1) -34- , 200821372 Toluene 2〇1111, catalyst palladium acetate (n) 0.42g (0.0018m〇l), 3-stage butyl was added to a 5〇〇ml four-necked flask under nitrogen atmosphere. 1.5 g (0.0075 mol) of phosphine, after stirring for a few minutes, a solution of 2,7-dibromofluorene 3 0.4 g (0.094 mol) in toluene at 100 m was further stirred for 10 minutes. Then, after adding 200 ml of a toluene solution of aniline 18.3 g (0.196 mol), 15.86 g (0.165 mol) of sodium butoxide sodium salt was further added, and the mixture was heated under reflux for 4 hours to cause a reaction. After the reaction was completed, water was added to the vessel and extracted with diethyl ether. After dehydration with sodium sulfate, sodium sulfate was filtered off and the solvent was removed by rotary evaporator. ^ The crude product was purified by hydrazine column chromatography to give the specific compound (B-1). Synthesis Example 3

(A — 2) 除了將合成例1中使用的苯胺用4 -正丙基苯胺替代以 外,按照興合成例1相同的流程進行合成’得到化合物(A 一 2) 〇 -35- 200821372(A - 2) The synthesis was carried out in the same manner as in Synthesis Example 1 except that the aniline used in Synthesis Example 1 was replaced with 4-n-propylaniline to give a compound (A-2) 〇 -35- 200821372

除了將合成例2中使用的苯胺用4_正丙基苯胺替代以 外,按照與合成例2相同的流程進行合成,得到化合物(B 一 2) 〇 合成例5The compound (B-2) was synthesized by the same procedure as in Synthesis Example 2 except that the aniline used in Synthesis Example 2 was replaced with 4-n-propylaniline. Synthesis Example 5

(A — 3) 在500ml三頸燒瓶中將特定化合物(A- l)3.36g(0.01mol)、 T H F 1 0 0 m 1、胺化鈉1 · 5 6 g (0.0 4 m ο 1)進行混合。使該溶液加 熱回流 2小時。冷卻反應溶液,滴加環氧溴丙烷 3.42ml(0.04mol)。滴加結束後,加熱至80°C攪拌6小時。 通過旋轉蒸發儀除去THF後,加入氯仿。將該溶液依次用 -36- 200821372 1 〇 %鹽酸水溶液、飽和食鹽水進行分液洗滌。將有機層用 無水硫酸鎂乾燥,濾除無水硫酸鎂後,通過旋轉蒸發儀除 去溶劑。從有機層蒸餾除去溶劑。再通過氧化矽管柱層析 法進行精製,得到特定化合物(Α - 3)。特定化合物(A — 3 ) 包含如上述式所示的2種產物。 合成例6(A-3) Mixing a specific compound (A-1) with 3.36 g (0.01 mol), THF 1 0 0 m 1 , sodium azide 1 · 5 6 g (0.0 4 m ο 1) in a 500 ml three-necked flask . The solution was heated to reflux for 2 hours. The reaction solution was cooled, and 3.42 ml (0.04 mol) of epibromohydrin was added dropwise. After the completion of the dropwise addition, the mixture was heated to 80 ° C and stirred for 6 hours. After removing the THF by a rotary evaporator, chloroform was added. The solution was washed with a solution of -36-200821372 1 〇% hydrochloric acid aqueous solution and saturated brine. The organic layer was dried over anhydrous magnesium sulfate and filtered and evaporated. The solvent was distilled off from the organic layer. Further, it was purified by ruthenium oxide column chromatography to obtain a specific compound (Α - 3). The specific compound (A-3) contains two kinds of products as shown in the above formula. Synthesis Example 6

在500ml三頸燒瓶中將化合物(B-l)17.4g(0.05mol)、 DMSO 120ml、碳酸鉀16.59g(0.12mol)進行混合。將該溶 液在冰浴中冷卻後,滴加環氧溴丙烷16.44g(0.12mol)的 DMSO溶液160ml。滴加結束後,回到室溫,繼續攪拌48 小時。過濾反應溶液,濾液通過旋轉蒸發儀濃縮,再通過 真空泵除去過量加入的環氧溴丙烷。向所得粗產物中加入 2 0 0ml甲苯進行稀釋,將該液用蒸餾水lOOml洗滌4次。 加入硫酸鈉,放置1晚後,濾除硫酸鈉,通過旋轉蒸發儀 除去溶劑。將所得粗產物通過氧化矽管柱層析法進行精 製,得到特定化合物(B — 3 )。B — 3包含如上述式所示的2 種產物。 -37- 200821372 合成例7Compound (B-1), 17.4 g (0.05 mol), DMSO 120 ml, and potassium carbonate 16.59 g (0.12 mol) were mixed in a 500 ml three-necked flask. After the solution was cooled in an ice bath, 160 ml of a solution of 16.44 g (0.12 mol) of oxidized bromopropane in DMSO was added dropwise. After the addition was completed, return to room temperature and continue stirring for 48 hours. The reaction solution was filtered, and the filtrate was concentrated by a rotary evaporator, and the excess of the epibromo-bromopropane was removed by a vacuum pump. To the obtained crude product, 200 ml of toluene was added for dilution, and the solution was washed 4 times with 100 ml of distilled water. After adding sodium sulfate and allowing to stand for 1 night, sodium sulfate was filtered off, and the solvent was removed by a rotary evaporator. The obtained crude product was purified by yttrium oxide column chromatography to give a specific compound (B-3). B-3 contains two products as shown in the above formula. -37- 200821372 Synthesis Example 7

(A — 4) 除了將合成例5中使用的特定化合物(a - 1)替換成(A - 2)以外’按照與合成例5同樣的流程進行合成,得到特 定化合物(A - 4)。A - 4包含如上述示所示的2種產物。 合成例8(A-4) A specific compound (A-4) was obtained by the same procedure as in the synthesis example 5 except that the specific compound (a-1) used in the synthesis example 5 was replaced by (A-2). A-4 contains two products as shown above. Synthesis Example 8

除了將合成例6中使用的特定化合物(Β_ 1}替換成(Β - 2)以外’按照與合成例6同樣的流程進行合成,得到特 定化合物(Β — 4)。Β - 4包含如上述式所示的2種產物。 聚醯亞胺合成例1 將作爲四竣酸二酸酐的2,3,5-三羧基環戊基醋酸二酸 酐 112g(0.50 莫耳)和 l,3,3a,4,5,9b-六氫-8_ 甲基-5-(四氫 -38- .200821372 -2,5-二氧代-3-呋喃基)-奈[1,2-〇]-咲喃-1,3-二丽157运(0.50 莫耳),作爲二胺化合物的對-苯二胺96g(0.89莫耳)、 3,3’-(四甲基二矽氧烷·1,3-二基)二(丙胺)25g(0.10莫耳)和 3,6-二(4-胺基苯甲醯氧基)膽留烷13g(〇.020莫耳)、作爲單 胺的正十八烷基胺8· lg(0· 03 0莫耳)溶於960 g N-甲基-2-吡 咯烷酮中,使其在6 〇 °C下反應6小時。將得到的聚醯胺酸 溶液少量地分取出來,加入NMP,以固體成分濃度1〇 %的 溶液測定黏度,爲60mPa,s。接著,向得到的聚醯胺酸溶 • 液中追加2700g N -甲基-2-卩比略院酮,添加396gD比陡和409g 醋酸酐’使其在1 1 0 °C下脫水閉環4小時。醯亞胺化反應 後,將系統內的溶劑以新的r - 丁內酯進行溶劑置換(在本 操作中,將使用於醯亞胺化反應的吡啶和醋酸酐去除到系 統外),得到約2 0 0 0 g固體成分濃度1 5 wt%,固體成分濃度 6.0%時(r -丁內酯溶液)的溶液黏度16mPa.s,醯亞胺化率 約爲95 %的醯亞胺化聚合物(其作爲“聚醯亞胺(a — 〇”) 溶液。 聚醯亞胺合成例2 將作爲四羧酸二酸酐的2,3, 5-三羧基環戊基醋酸二酸 酐2 2 4 g ( 1 · 0莫耳),作爲二胺化合物的對·苯二胺1 〇 8 g 〇 . 〇 莫耳)和3,5-二胺基苯甲酸膽甾烷基酯7.8g(0.015莫耳)溶 於3 0 3 9 g N -甲基-2 ·吡咯烷酮中,使其在6 0。(:下反應6小 時,從而得到溶液黏度約爲260mPa.s的聚醯胺酸溶液。接 著,向得到的聚醯胺酸溶液中追加2 7 0 0 g N -甲基-2 -吡略院 酮,添加396g吡啶和306g醋酸酐,使其在ll〇°C下脫水 -39- 200821372 閉環4小時。醯亞胺化反應後,將系統內的溶劑以新的7 -丁內酯進行溶劑置換(在本操作中,將使用於醯亞胺化反應 的吡啶和醋酸酐去除到系統外),得到約3 000g固體成分濃 度9.0wt%,固體成分濃度5.0%時(r -丁內酯溶、液)的溶液 黏度72mPa,s,醯亞胺化率約爲89%的醯亞胺化聚合物(其 作爲“醯亞胺化聚合物(a - 2)” )溶液。 聚醯胺酸合成例1 將作爲四羧酸二酸酐的1,2,3,4-環丁烷四羧酸二酸酐 196g(1.0莫耳),作爲二胺化合物的2,25·二甲基-4,4’-二胺 基聯苯 212g(1.0莫耳)溶於 3 70g N-甲基-2-吡咯烷酮和 3 3 00g r -丁內酯,使其在40°C下反應3小時,得到約3700g 溶液黏度爲160mPa,s的聚醯胺酸(其作爲“聚醯胺酸(b-1)” )溶液。 聚醯胺酸合成例2 將作爲四羧酸二酸酐的1,2,3,4-環丁烷四羧酸二酸酐 9 5g(0.50莫耳)、均苯四酸二酸酐l〇9g(0.50莫耳),作爲二 胺化合物的2,7-二胺基芴196g(l.〇莫耳)溶於230gN-甲基 -2-吡咯烷酮和2060g r -丁內酯,使其在40°C下反應3小 時之後,追加1 3 5 0g r -丁內酯,得到約3600g固體成分 濃度10%的溶液黏度125mPa.s的聚醯胺酸(其作爲“聚醯 胺酸(b — 2)”)溶液。 實施例1 將聚醯亞胺合成例1中製得的聚醯亞胺(a - 1)和聚醯 胺酸合成例1中製得的聚醯胺酸(b- 1)以聚醯亞胺:聚醯 -40- 200821372 胺酸= 20: 80(重量比)溶於γ-丁內酯/N-甲基-2-吡咯烷酮/ 丁基溶纖劑混合溶劑(重量比71/1 7/12)中,相對於100重 量份聚合物加入2重量份N,N,N’,N’-四縮水甘油基-4,4’-二胺基二苯基甲烷,相對於1 〇〇重量份聚合物加入1 〇重量 份特定化合物(A — 1),製成固體成分濃度爲3.5重量%的溶 液和6.0重量%的溶液。將各溶液充分攪拌後,用孔徑爲Ιμπι 的濾器過濾,調製出本發明的液晶配向劑。 使用旋塗機將上述液晶配向劑中固體成分濃度爲3.5重 • 量°/〇的溶液塗敷於厚度爲1mm的玻璃基板的一面上所設置 的由ITO膜形成的透明導電膜上(轉速:2500rpm,塗敷時 間:1分鐘),在200°C下乾燥1小時,形成乾燥膜厚爲0.08μιη 的覆膜。使用裝有纒繞人造纖維製的布的輥的打磨機,在 輥轉速爲400 rpm、操作臺移動速度爲3cm/秒,絨毛押入 ' 長度爲〇.4mm的條件下,對該覆膜進行打磨處理。在超純 水中進行1分鐘超音波洗滌,用100°C的清潔烤箱乾燥1〇 分鐘。然後,在一對透明電極/透明電極基板的上述液晶配 ® 向膜塗敷基板的具有液晶配向膜的各外緣上,塗敷加入了 直徑爲5 · 5 μπι的氧化鋁球的環氧樹脂接著劑,然後,使液 晶配向膜面相對地重合並壓合,使接著劑固化。接著,通 過液晶注入口向基板間塡充向列型液晶(默克社製, MLC-622 1 ),然後用丙烯酸類光固化接著劑將液晶注入口 封閉,製成本發明的液晶顯示元件。對所得液晶顯示元件 的電壓保持率和殘影的評價按照以上所述的方法進行。 使用固體成分濃度爲6.0重量%的溶液,按照以上所述 -41 200821372 的方法進行印刷性評價。 · 實施例2〜8 除了聚醯亞胺、聚醯胺酸、特定化合物使用表1中所 示的物質以外,按照與實施例1同樣的流程進行。 實施例9 將聚醯亞胺合成例2中製得的聚醯亞胺(a - 2)溶於N_ 甲基-2 -耻咯院酮/ 丁基溶纖劑混合溶劑(重量比5 0 / 5 0 )中, 相對於1〇〇重量份聚合物加入2重量份N,N,N’,N’-四縮水甘 ® 油基-4,4’-二胺基二苯基甲烷,相對於1〇0重量份聚合物加 入10重量份特定化合物(A - 1),製成固體成分濃度爲3.5 重量%的溶液和6.0重量%的溶液。將各溶液充分攪拌後, 用孔徑爲1 μπι的濾器過濾,調製出本發明的液晶配向劑。液 晶顯示元件的製作方法、液晶顯示元件的評價方法以及配向 劑印刷性的評價方法按照與實施例1相同的方法進行。 實施例1 0〜1 2 除了特定化合物使用表1中所示的物質以外,按照與 1 實施例9同樣的流程進行。 比較例1〜2 除了聚醯亞胺、聚醯胺酸使用表1中所示的物質’並 且不添加特定化合物以外,按照與實施例1同樣的流g 31 行。 比較例3 除了不添加特定化合物以外,按照與實施例9同_ @ 流程進行。 -42- 200821372 比較例4〜5 除了聚醯亞胺、聚醯胺酸使用表1中所示的物質,並 使用N,N’-二苯基-N,N’-二(間甲苯基)聯苯胺(化合物Z)代 替特定化合物以外,按照與實施例1同樣的流程進行。 比較例6 除了使用N,N’-二苯基·Ν,Ν’_二(間甲苯基)聯苯胺(化 合物Ζ)代替特定化合物以外,按照與實施例9同樣的流程 進行。The specific compound (Β-4) was obtained by the same procedure as in Synthesis Example 6 except that the specific compound (Β_1} used in Synthesis Example 6 was replaced by (Β-2). Β-4 contained the above formula. Two products shown. Polyimine synthesis Example 1 2,3,5-tricarboxycyclopentyl acetic acid dianhydride as tetraterpene dianhydride 112 g (0.50 mol) and 1,3,3a,4 ,5,9b-hexahydro-8-methyl-5-(tetrahydro-38-.200821372-2,5-dioxo-3-furanyl)-na[1,2-indole]-pyran-1 , 3-Beli 157 (0.50 mol), p-phenylenediamine as diamine compound 96g (0.89 mol), 3,3'-(tetramethyldioxane·1,3-diyl Bis (propylamine) 25 g (0.10 mol) and 3,6-bis(4-aminobenzylideneoxy)cholalane 13 g (〇.020 mol), n-octadecylamine as a monoamine 8· lg (0·03 0 mole) is dissolved in 960 g of N-methyl-2-pyrrolidone and allowed to react at 6 ° C for 6 hours. The obtained polyamidamine solution is taken out in small portions. NMP was added, and the viscosity was measured by a solution having a solid concentration of 1% by weight, which was 60 mPa, s. Then, the obtained polylysine was dissolved. • Add 2700 g of N-methyl-2-indole ketone to the solution, add 396 g of D-steep and 409 g of acetic anhydride to dehydrate the mixture for 4 hours at 110 ° C. After the imidization reaction, the system The solvent in the solvent is replaced by a new r-butyrolactone (in this operation, the pyridine and acetic anhydride used in the oxime imidization reaction are removed to the outside of the system) to obtain a solid concentration of about 2,000 g. 5 wt%, a solid concentration of 6.0% (r-butyrolactone solution), a solution viscosity of 16 mPa.s, and a ruthenium iodide ratio of about 95% of the ruthenium iodide (which acts as a "polyimine ( a — 〇”) solution. Polyimine synthesis example 2 2,4,5-tricarboxycyclopentyl acetic acid dianhydride as tetracarboxylic dianhydride 2 2 4 g (1·0 mol) as two The amine compound p-phenylenediamine 1 〇8 g 〇. 〇mol) and 3,5-diaminobenzoic acid cholesteryl ester 7.8 g (0.015 mol) dissolved in 3 0 3 9 g N-A In the thiopyrrolidone, it is subjected to a reaction at 60 ° for 6 hours to obtain a polyaminic acid solution having a solution viscosity of about 260 mPa·s. Next, a further addition of 2 7 to the obtained poly-proline solution is obtained. 0 0 g N-methyl-2-pyrrolidone, adding 396 g of pyridine and 306 g of acetic anhydride, dehydrating at ll ° ° C -39-200821372 closed-loop for 4 hours. After the hydrazine imidization reaction, the solvent in the system was The new 7-butyrolactone is subjected to solvent replacement (in this operation, the pyridine and acetic anhydride used in the oxime imidization reaction are removed to the outside of the system) to obtain a solid concentration of about 3,000 wt%, a solid concentration of 5.0. % (r-butyrolactone solution, liquid) solution viscosity 72mPa, s, yttrium imidization rate of about 89% yttrium imidized polymer (as a "noniminated polymer (a - 2) ”) solution. Polylysine Synthesis Example 1 196 g (1.0 mol) of 1,2,3,4-cyclobutanetetracarboxylic acid dianhydride as tetracarboxylic acid dianhydride as 2,25·dimethyl group of diamine compound -4,4'-diaminobiphenyl 212 g (1.0 mol) was dissolved in 3 70 g of N-methyl-2-pyrrolidone and 3 3 00 g of r-butyrolactone, and allowed to react at 40 ° C for 3 hours. A solution of about 3700 g of a solution having a viscosity of 160 mPa, s poly-proline (as a "poly-proline (b-1)") solution was obtained. Polylysine Synthesis Example 2 1,5,3,3,4-cyclobutanetetracarboxylic acid dianhydride as tetracarboxylic acid dianhydride, 95 g (0.50 mol), pyromellitic dianhydride l 9 g (0.50) Mohr), 2,7-diaminopurine as a diamine compound, 196 g (l. mol) dissolved in 230 g of N-methyl-2-pyrrolidone and 2060 g of r-butyrolactone at 40 ° C After reacting for 3 hours, 1 3 5 0 g r -butyrolactone was added to obtain about 3600 g of a polyamic acid having a solid concentration of 10% and a solution viscosity of 125 mPa.s (as "polyglycine (b-2)"). Solution. Example 1 Polyimine (a-1) prepared in Polyimine Synthesis Example 1 and Polylysine (b-1) prepared in Polyamine Synthesis Example 1 as Polyimine :聚醯-40- 200821372 Amino acid = 20: 80 (weight ratio) dissolved in γ-butyrolactone / N-methyl-2-pyrrolidone / butyl cellosolve mixed solvent (weight ratio 71/1 7/12) Adding 2 parts by weight of N,N,N',N'-tetraglycidyl-4,4'-diaminodiphenylmethane to 100 parts by weight of the polymer, relative to 1 part by weight of the polymer 1 part by weight of a specific compound (A-1), a solution having a solid concentration of 3.5% by weight and a solution of 6.0% by weight. After the respective solutions were thoroughly stirred, they were filtered through a filter having a pore size of Ιμπι to prepare a liquid crystal alignment agent of the present invention. A solution having a solid concentration of 3.5 parts by weight / 〇 in the above liquid crystal alignment agent was applied to a transparent conductive film formed of an ITO film provided on one side of a glass substrate having a thickness of 1 mm using a spin coater (rotation speed: 2500 rpm, coating time: 1 minute), and dried at 200 ° C for 1 hour to form a film having a dry film thickness of 0.08 μm. Using a sander equipped with a roller of a woven fabric made of rayon, the film was ground at a roller speed of 400 rpm, a table moving speed of 3 cm/sec, and a fluffing length of 〇.4 mm. deal with. Ultrasonic washing was performed in ultrapure water for 1 minute and dried in a 100 °C clean oven for 1 minute. Then, on each of the outer edges of the liquid crystal alignment film of the liquid crystal alignment film coating substrate of the pair of transparent electrode/transparent electrode substrates, an epoxy resin coated with alumina balls having a diameter of 5 · 5 μm is applied. Subsequently, the liquid crystal alignment film surface is relatively recombined and pressed to cure the adhesive. Then, a nematic liquid crystal (MLC-622 1 manufactured by Merck & Co., Ltd.) was filled between the substrates through a liquid crystal injection port, and then the liquid crystal injection port was sealed with an acrylic photocurable adhesive to form a liquid crystal display element of the present invention. The evaluation of the voltage holding ratio and the afterimage of the obtained liquid crystal display element was carried out in accordance with the method described above. The printability evaluation was carried out by the method of -41 200821372 using the solution having a solid content concentration of 6.0% by weight. Examples 2 to 8 were carried out in the same manner as in Example 1 except that the materials shown in Table 1 were used for the polyimine, the polyamic acid, and the specific compound. Example 9 Polyethylenimine (a-2) prepared in Polyimine Synthesis Example 2 was dissolved in a mixed solvent of N_methyl-2-miraxolone/butyl cellosolve (weight ratio 5 0 / 5 0 In the case of adding 2 parts by weight of N,N,N',N'-tetraglycidyl oil-based-4,4'-diaminodiphenylmethane relative to 1 part by weight of the polymer, relative to 1 〇 0 parts by weight of the polymer was added to 10 parts by weight of the specific compound (A-1) to prepare a solution having a solid concentration of 3.5% by weight and a solution of 6.0% by weight. After each solution was thoroughly stirred, it was filtered with a filter having a pore size of 1 μm to prepare a liquid crystal alignment agent of the present invention. The method for producing a liquid crystal display device, the method for evaluating a liquid crystal display device, and the method for evaluating the printability of an alignment agent were carried out in the same manner as in Example 1. Example 1 0 to 1 2 The same procedure as in Example 9 was carried out except that the specific compound was used as shown in Table 1. Comparative Examples 1 to 2 The same flow g 31 as in Example 1 was carried out except that the material shown in Table 1 was used for the polyimine and the polyamic acid, and the specific compound was not added. Comparative Example 3 was carried out in the same manner as in Example 9 except that no specific compound was added. -42- 200821372 Comparative Examples 4 to 5 In addition to polyimine and polylysine, the materials shown in Table 1 were used, and N,N'-diphenyl-N,N'-di(m-tolyl) was used. The same procedure as in Example 1 was carried out except that benzidine (Compound Z) was used instead of the specific compound. Comparative Example 6 The same procedure as in Example 9 was carried out except that N,N'-diphenylanthracene, yttrium-di(m-tolyl)benzidine (compound) was used instead of the specific compound.

聚醯亞胺 聚醯胺酸 特定化合物 電壓保持率 殘影 印刷性 實施例1 a— 1 b- 1 特定化合物A_1 >99% 〇 〇 實施例2 a— 1 b— 1 特定化合物B- 1 >99% 〇 〇 實施例3 a— 1 b— 1 特定化合物A—4 >99% 〇 〇 實施例4 a— 1 b— 1 特定化合物B-4 >99% 〇 〇 實施例5 a— 1 b-2 特定化合物A-3 >99% 〇 〇 實施例6 a— 1 b-2 特定化合物B-3 >99% 〇 〇 實施例7 a— 1 b-2 特定化合物A-4 >99% 〇 〇 實施例8 a— 1 b-2 特定化合物B-4 >99% 〇 〇 實施例9 a—2 — 特定化合物A-1 >99% 〇 〇 實施例10 a— 2 — 特定化合物B- 1 >99% 〇 〇 實施例11 a— 2 — 特定化合物A-4 >99% 〇 〇 實施例12 a— 2 — 特定化合物B-4 >99% 〇 〇 比較例1 a- 1 b- 1 Μ /\\\ >99% Δ 〇 比較例2 a— 1 b-2 4Ε /\\\ >99% Δ 〇 比較例3 a— 2 — 4rrr. >99% Δ 〇 比較例4 a— i b — 1 化合物Ζ 98% 〇 X 比較例5 a— 1 b-2 化合物ζ 98% 〇 X 比較例6 a— 2 — 化合物ζ 98% 〇 X 表中,〇··優,△:良,X:差 -43- 200821372 【圖式簡單說明】^ 第1圖爲殘影實驗而製作的晶胞的說明圖。 -44-Polyimine polyamine specific compound voltage retention rate image-printing Example 1 a-1 b- 1 Specific compound A_1 > 99% 〇〇 Example 2 a-1 b-1 Specific compound B-1 &gt 99% 〇〇Example 3 a-1 b-1 Specific compound A-4 > 99% 〇〇 Example 4 a-1 b-1 Specific compound B-4 > 99% 〇〇 Example 5 a- 1 b-2 specific compound A-3 > 99% 〇〇 Example 6 a-1 b-2 Specific compound B-3 > 99% 〇〇 Example 7 a-1 b-2 Specific compound A-4 &gt 99% 〇〇Example 8 a-1 b-2 Specific compound B-4 > 99% 〇〇 Example 9 a-2 - Specific compound A-1 > 99% 〇〇 Example 10 a-2 Specific Compound B-1 > 99% 〇〇 Example 11 a-2 - Specific Compound A-4 > 99% 〇〇 Example 12 a-2 - Specific Compound B-4 > 99% 〇〇 Comparative Example 1 A- 1 b- 1 Μ /\\\ >99% Δ 〇Comparative Example 2 a-1 b-2 4Ε /\\\ >99% Δ 〇Comparative Example 3 a— 2 — 4rrr. >99% Δ 〇Comparative Example 4 a— ib — 1 Compound Ζ 98% 〇X Comparative Example 5 a-1 b-2 ζ 98% 〇X Comparative Example 6 a-2 — Compound ζ 98% 〇X In the table, 〇·· excellent, △: good, X: poor-43- 200821372 [Simple illustration] ^ Figure 1 is the residual An explanatory diagram of a unit cell produced by a shadow experiment. -44-

Claims (1)

200821372 十、申請專利範圍: 1·一種液晶配向劑,其特徵在於含有從由下述式(A)表示的 化合物和下述式(B)表示的化合物所構成群組選出的至 少一種化合物,200821372 X. Patent application scope: 1. A liquid crystal alignment agent characterized by containing at least one compound selected from the group consisting of a compound represented by the following formula (A) and a compound represented by the following formula (B). (式中,Ri〜R8各自獨立地爲氫原子、烷基、烷氧基或 者芳香族基團,R9和Rn爲芳香族基團,且R1()和R12 各自獨立地爲氫原子、烷基或縮水甘油基),(wherein, Ri to R8 are each independently a hydrogen atom, an alkyl group, an alkoxy group or an aromatic group, R9 and Rn are an aromatic group, and R1() and R12 are each independently a hydrogen atom or an alkyl group; Or glycidyl), 尺16〆Ruler 16〆 R 18 (B) (式中,R 1 3和R 1 4各自獨立地爲氫原子、院基、院氧基 或者芳香族基團,R!5和Ru爲芳香族基團,R16和R18 各自獨立地爲氫原子、烷基或縮水甘油基,且X表示2 價的有機基團、-〇-或者-NH-)。 2·如申請專利範圍第1項之液晶配向劑,其中式(A)中的Rl〇 和R12的脂肪族基團爲含環氧基的脂肪族基團。 3.如申請專利範圍第1項之液晶配向劑,其中式(B)中的R16 和R! 8的脂肪族基團爲含環氧基的脂肪族基團。 -45 - 200821372 4 ·如申請專利範圍第1至3項中任一項之液晶配向劑, 其中進一步含有經由下述式(I - 1 )表示的聚醯胺酸和下 述式(I - 2)表示的聚醯亞胺所構成群組選出的至少一種 聚合物 HOOC、 .COOH (I 一 1) X HNOC CONH—Q1R 18 (B) (wherein R 1 3 and R 1 4 are each independently a hydrogen atom, a substituent, an aristocratic group or an aromatic group, R!5 and Ru are aromatic groups, and R16 and R18 are each Independently a hydrogen atom, an alkyl group or a glycidyl group, and X represents a divalent organic group, -〇- or -NH-). 2. The liquid crystal alignment agent of claim 1, wherein the aliphatic group of R1〇 and R12 in the formula (A) is an epoxy group-containing aliphatic group. 3. The liquid crystal alignment agent of claim 1, wherein the aliphatic group of R16 and R! 8 in the formula (B) is an epoxy group-containing aliphatic group. The liquid crystal alignment agent according to any one of claims 1 to 3, further comprising a polyaminic acid represented by the following formula (I-1) and the following formula (I-2) At least one polymer selected from the group consisting of polyimine, HOOC, .COOH (I-1) X HNOC CONH-Q1 式中,P2爲4價的有機基團,且Q2爲2價的有機基團。 5 ·如申請專利範圍第4項之液晶配向劑,其中上述式(I 一 1) 表示的聚醯胺酸和上述式(I - 2)表示的聚醯亞胺合成中 所用的四羧酸二酸酐包含2,3,5-三羧基環戊基醋酸二酸 酐。 6. —種液晶配向膜,其採用如申請專利範圍第1至5項中 任一項之液晶配向劑製得。 7. 一種液晶顯示元件,其特徵在於具有如申請專利範圍第6 項之液晶配向膜。 -46-In the formula, P2 is a tetravalent organic group, and Q2 is a divalent organic group. 5. The liquid crystal alignment agent of claim 4, wherein the polyamic acid represented by the above formula (I-1) and the tetracarboxylic acid used in the synthesis of the polyimine represented by the above formula (I-2) The acid anhydride comprises 2,3,5-tricarboxycyclopentyl acetic acid dianhydride. A liquid crystal alignment film produced by using a liquid crystal alignment agent according to any one of claims 1 to 5. A liquid crystal display element characterized by having a liquid crystal alignment film according to item 6 of the patent application. -46-
TW096131758A 2006-08-29 2007-08-28 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element TWI457421B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006232107 2006-08-29

Publications (2)

Publication Number Publication Date
TW200821372A true TW200821372A (en) 2008-05-16
TWI457421B TWI457421B (en) 2014-10-21

Family

ID=39159971

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096131758A TWI457421B (en) 2006-08-29 2007-08-28 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Country Status (3)

Country Link
KR (1) KR101408469B1 (en)
CN (1) CN101135813B (en)
TW (1) TWI457421B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5365780B2 (en) * 2008-03-18 2013-12-11 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element
JP5773116B2 (en) * 2009-12-03 2015-09-02 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element
KR102273687B1 (en) 2018-05-17 2021-07-05 주식회사 엘지화학 Liquid crystal alignment composition, method of preparing liquid crystal alignment film, and liquid crystal alignment film using the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2407704A (en) * 1944-01-01 1946-09-17 Allied Chem & Dye Corp Anthraquinone acid dyestuff
JP3536925B2 (en) * 1993-05-18 2004-06-14 チッソ株式会社 Liquid crystal alignment film and liquid crystal display device
JPH07309351A (en) * 1994-05-17 1995-11-28 Idemitsu Petrochem Co Ltd Bag with fastener
JP3206401B2 (en) * 1995-11-20 2001-09-10 ジェイエスアール株式会社 Liquid crystal alignment agent and liquid crystal display device
TWI291065B (en) 2000-12-26 2007-12-11 Nissan Chemical Ind Ltd Diamines, polyimide precursors and polyimides produced by using the diamines, and liquid crystal aligning agents
JP4045595B2 (en) * 2003-04-22 2008-02-13 Jsr株式会社 Liquid crystal alignment agent
JP4502119B2 (en) * 2004-06-24 2010-07-14 Jsr株式会社 Vertical liquid crystal display device having a reflective electrode
JP4434862B2 (en) * 2004-07-08 2010-03-17 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element

Also Published As

Publication number Publication date
KR20080020520A (en) 2008-03-05
TWI457421B (en) 2014-10-21
CN101135813B (en) 2011-03-16
KR101408469B1 (en) 2014-06-17
CN101135813A (en) 2008-03-05

Similar Documents

Publication Publication Date Title
JP4978433B2 (en) Liquid crystal aligning agent and liquid crystal display element
TW201005005A (en) Liquid crystal alignment agent and liquid crystal display element
TW200811553A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI445736B (en) Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display element
TWI457667B (en) Liquid crystal alignment agent and liquid crystal display element
TW200946563A (en) Liquid crystal aligning agent and liquid crystal display element
TW200903116A (en) Liquid crystal aligning agent and liquid crystal display
TWI501011B (en) Liquid crystal aligning agent and liquid crystal display element
TWI444727B (en) Liquid crystal alignment agent and liquid crystal display element
TWI427103B (en) Liquid crystal aligning agent and liquid crystal display element
TWI359175B (en)
JP2008090297A (en) Liquid crystal aligning agent and liquid crystal display element
TWI428370B (en) Liquid crystal aligning agent and liquid crystal display element
TWI354843B (en) Liquid crystal alignment agent and liquid crystal
JP2009053666A (en) Liquid crystal aligning agent, liquid crystal alignment layer and liquid crystal display element
JP2008107814A (en) Liquid crystal aligning agent, liquid crystal alignment layer and liquid crystal display element
JP5045913B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP4978434B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP5293927B2 (en) Liquid crystal aligning agent and liquid crystal display element
TWI457421B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI422930B (en) Liquid crystal alignment agent and liquid crystal display element
TW200831562A (en) Liquid crystal alignment agent and liquid crystal display element
JP4924832B2 (en) Liquid crystal aligning agent and liquid crystal display element
TW200925181A (en) Liquid crystal alignmenting agent and transverse electric field type liquid crystal display element
JP5099351B2 (en) Liquid crystal aligning agent and liquid crystal display element

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent